Body and Mind (BMMJ) 10-Q 21 Jun 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Apr. 30, 2022	Jun. 20, 2022
Cover [Abstract]
Entity Registrant Name	BODY AND MIND INC.
Entity Central Index Key	0001715611
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--07-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Apr. 30, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Entity Ex Transition Period	true
Entity Common Stock Shares Outstanding		113,349,464
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55940
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-1319227
Entity Interactive Data Current	Yes
Entity Address Address Line 1	750 – 1095 West Pender Street
Entity Address City Or Town	Vancouver
Entity Address Country	CA
Entity Address Postal Zip Code	V6E 2M6
City Area Code	800
Local Phone Number	361-6312
Entity Address State Or Province	BC

Condensed Consolidated Interim

Condensed Consolidated Interim Balance Sheets - USD ($)	Apr. 30, 2022	Jul. 31, 2021
Current
Cash	$ 3,706,894	$ 7,374,194
Amounts receivable	817,936	1,544,957
Interest receivable on convertible loan (Note 6)	204,000	150,000
Prepaids	685,763	413,246
Inventory (Note 5)	4,319,904	2,936,156
Convertible loan receivable (Note 6)	1,893,252	1,648,816
Loan receivable (Note 7)	239,834	239,834
Total Current Assets	11,867,583	14,307,203
Deposit	113,828	470,546
Loan receivable from NMG Ohio LLC (Note 8)	0	891,279
Property and equipment, net (Note 10)	5,691,657	4,893,790
Operating lease right-of-use assets (Note 15)	6,306,767	2,539,023
Brand and licenses, net (Note 12)	23,063,866	19,855,068
Goodwill (Note 12)	5,947,498	5,168,902
TOTAL ASSETS	52,991,199	48,125,811
Current
Accounts payable	2,138,784	1,686,376
Accrued liabilities	102,000	105,538
Income taxes payable	6,254,200	3,832,078
Due to related parties (Note 13)	46,720	52,074
Loans payable (Note 14)	16,962	16,874
Current portion of operating lease liabilities (Note 15)	886,202	761,415
Total Current Liabilities	9,444,868	6,454,355
Long-term operating lease liabilities (Note 15)	5,084,579	2,323,525
Loans payable (Note 14)	7,455,603	4,798,871
Deferred tax liability	714,356	198,339
TOTAL LIABILITIES	22,699,406	13,775,090
STOCKHOLDERS' EQUITY
Capital Stock- Statement 3 (Note 16) Authorized: 900,000,000 Common Shares - Par Value $0.0001 Issued and Outstanding: 113,349,464 (31 July 2021-109,077,778) Common Shares	11,334	10,907
Additional paid-in capital	52,184,483	50,312,013
Accumulated other comprehensive income	1,057,793	1,127,713
Accumulated Deficit	(23,322,485)	(17,126,510)
TOTAL STOCKHOLDERS' EQUITY ATTRIBUTABLE TO BAM STOCKHOLDERS	29,931,125	34,324,123
NON-CONTROLLING INTEREST	360,668	26,598
TOTAL STOCKHOLDERS' EQUITY	30,291,793	34,350,721
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 52,991,199	$ 48,125,811

Condensed Consolidated Interi_2

Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2022	Jul. 31, 2021
Condensed Consolidated Interim Balance Sheets
Common stock, shares authorized	900,000,000	900,000,000
Common stock, par value per share	$ 0.0001	$ 0.0001
Common stock, shares issued	113,349,464	109,077,778
Common Stock, shares outstanding	113,349,464	109,077,778

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Operations (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
Condensed Consolidated Interim Statements of Operations (unaudited)
Sales	$ 7,876,674	$ 7,156,016	$ 23,494,016	$ 18,765,785
Cost of sales	(4,969,619)	(2,882,750)	(14,072,787)	(9,944,479)
Gross Profit	2,907,055	4,273,266	9,421,229	8,821,306
General and Administrative Expenses
Accounting and legal	147,289	238,876	698,133	704,890
Business development	390,555	863,589	565,630	876,925
Consulting fees	259,722	133,584	650,929	325,666
Depreciation and amortization	445,656	289,920	1,214,981	832,627
Lease expense	267,715	102,029	600,178	292,660
Licenses, utilities and office administration	1,268,447	770,793	3,350,992	2,151,184
Management fees	49,778	84,676	338,815	305,432
Salaries and wages	1,326,073	837,565	3,610,271	2,393,620
Stock-based compensation	91,383	244,276	386,327	733,098
Total Operating Expense	(4,246,618)	(3,565,308)	(11,416,256)	(8,616,102)
Net Operating Income (Loss) Before Other Income (Expenses)	(1,339,563)	707,958	(1,995,027)	205,204
Other Income (Expenses)
Foreign exchange, net	10	(90)	324	140
Interest expense	(338,185)	(1,357)	(1,016,969)	(2,684)
Interest income	18,000	21,252	54,000	146,619
Other income (expense)	18,952	8,625	34,906	(107,336)
Gain on bargain purchase	0	0	0	208,176
Equity-method investment change from earnings	0	(11,653)	0	13,219
Net Income (Loss) for the Period Before Income Tax	(1,640,786)	724,735	(2,922,766)	463,338
Income tax expense	(821,317)	(976,458)	(2,939,139)	(2,640,527)
Net Loss for the Period	(2,462,103)	(251,723)	(5,861,905)	(2,177,189)
Other Comprehensive Income
Foreign currency translation adjustment	(71,041)	(349,334)	(69,920)	0
Comprehensive Loss for the Period	(2,533,144)	(601,057)	(5,931,825)	(2,177,189)
Net income (loss) attributable to:
Body and Mind Inc.	(2,530,064)	(353,637)	(6,195,975)	(2,341,082)
Non-controlling interest	67,961	101,914	334,070	163,893
Comprehensive income (loss) attributable to:
Body and Minds Inc.	(2,601,105)	(702,971)	(6,265,895)	(2,341,082)
Non-controlling interests	$ 67,961	$ 101,914	$ 334,070	$ 163,893
Loss per Share - Basic and Diluted	$ (0.02)	$ 0	$ (0.05)	$ (0.02)
Weighted Average Number of Shares Outstanding	113,349,464	108,818,789	111,806,303	108,255,847

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Changes in Stockholders Equity (unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Shares To Be Issued	Other Comprehensive Income	Accumulated Deficit	Non-Controlling Interest
Balance, shares at Jul. 31, 2020		107,513,812
Balance, amount at Jul. 31, 2020	$ 33,304,449	$ 10,751	$ 47,665,678	$ 19,703	$ 731,768	$ (14,865,608)	$ (257,843)
Common stock issued in acquisition of NMG Ohio LLC, shares		793,466
Common stock issued in acquisition of NMG Ohio LLC, amount	297,042	79	296,963	0	0	0	0
Stock-based compensation (Note 16)	287,631	0	287,631	0	0	0	0
Foreign currency translation adjustment	268,097	0	0	0	268,097	0	0
Loss (income) for the period	(778,367)	0	0	0	0	(792,545)	14,178
Balance, amount at Oct. 31, 2020	33,378,852	$ 10,830	48,250,272	19,703	999,865	(15,658,153)	(243,665)
Balance, shares at Oct. 31, 2020		108,307,278
Stock-based compensation (Note 16)	201,191	$ 0	201,191	0	0	0	0
Foreign currency translation adjustment	81,237	0	0	0	81,237	0	0
Loss (income) for the period	(1,147,100)	$ 0	0	0	0	(1,194,901)	47,801
Escrow release, shares		70,500
Escrow release, amount	0	$ 7	19,696	(19,703)	0	0	0
Balance, amount at Jan. 31, 2021	32,514,180	$ 10,837	48,471,159	0	1,081,102	(16,853,054)	(195,864)
Balance, shares at Jan. 31, 2021		108,377,778
Stock-based compensation (Note 16)	244,276	$ 0	244,276	0	0	0	0
Foreign currency translation adjustment	(27,046)	0	0	0	(27,046)	0	0
Loss (income) for the period	(251,723)	$ 0	0	0	0	(353,636)	101,914
Exercise of options, shares		700,000
Exercise of options, amount	317,045	$ 70	316,975	0	0	0	0
Balance, amount at Apr. 30, 2021	32,796,733	$ 10,907	49,032,410	0	1,054,056	(17,206,690)	(93,950)
Balance, shares at Apr. 30, 2021		109,077,778
Balance, shares at Jul. 31, 2021		109,077,778
Balance, amount at Jul. 31, 2021	34,350,721	$ 10,907	50,312,013	0	1,127,713	(17,126,510)	26,598
Stock-based compensation (Note 16)	145,175	0	145,175	0	0	0	0
Foreign currency translation adjustment	36,281	0	0	0	36,281	0	0
Loss (income) for the period	(677,254)	$ 0	0	0	0	(789,089)	111,835
Common stock issued for lease liabilities, shares		1,543,530
Common stock issued for lease liabilities, amount	547,026	$ 154	546,872	0	0	0	0
Balance, amount at Oct. 31, 2021	34,401,949	$ 11,061	51,004,060	0	1,163,994	(17,915,599)	138,433
Balance, shares at Oct. 31, 2021		110,621,308
Stock-based compensation (Note 16)	149,769	$ 0	149,769	0	0	0	0
Foreign currency translation adjustment	(35,160)	0	0	0	(35,160)	0	0
Loss (income) for the period	(2,722,548)	$ 0	0	0	0	(2,876,822)	154,274
Common stock issued in acquisition of Canopy, shares		2,782,156
Common stock issued in acquisition of Canopy, amount	939,544	$ 273	939,271	0	0	0	0
Balance, amount at Jan. 31, 2022	32,733,554	$ 11,334	52,093,100	0	1,128,834	(20,792,421)	292,707
Balance, shares at Jan. 31, 2022		113,349,464
Stock-based compensation (Note 16)	91,383	$ 0	91,383	0	0	0	0
Foreign currency translation adjustment	(71,041)	0	0	0	(71,041)	0	0
Loss (income) for the period	(2,462,103)	0	0	0	0	(2,530,064)	67,961
Balance, amount at Apr. 30, 2022	$ 30,291,793	$ 11,334	$ 52,184,483	$ 0	$ 1,057,793	$ (23,322,485)	$ 360,668
Balance, shares at Apr. 30, 2022		113,349,464

Condensed Consolidated Interi_5

Condensed Consolidated Interim Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Operating Activities
Net loss for the period	$ (5,861,905)	$ (2,177,189)
Items not affecting cash:
Amortization of debt discount	356,732	0
Accrued interest income	(54,000)	(54,000)
Amortization of licenses	1,061,202	775,692
Non-cash costs - operating leases	719,096	292,660
Depreciation	709,241	379,043
Foreign exchange	0	(130,125)
Equity-method investment change from earnings	0	(24,872)
Gain on bargain purchase	0	(208,176)
Stock-based compensation	386,327	733,098
Amounts receivable and prepaids	493,515	(253,482)
Inventory	(731,072)	(1,391,032)
Deposits	(113,828)	0
Trade payables and accrued liabilities	127,827	(276,126)
Income taxes payable and deferred taxes	2,938,139	2,574,933
Due to related parties	(5,354)	(15,228)
Operating lease liabilities	(583,427)	(246,325)
Cash used in operating activities	557,507	21,129
Investing Activities
Investment in NMG Ohio, LLC , net of cash received	(54,415)	(136,326)
Loan to NMG Ohio LLC	0	(228,736)
Investment in GLDH, net of cash received	0	97,706
Cash paid in acquisition of Canopy, net of cash received	(2,121,497)	0
Purchase of property and equipment	(619,613)	(275,433)
Acquisition of NMG LB, net of cash received	0	65,340
Convertible loan receivable	(244,436)	(164,947)
Cash used in investing activities	(3,039,961)	(642,396)
Financing Activities
Proceeds from option exercises	0	317,045
Loans received	22,194	0
Loans repaid	(22,106)	(12,190)
Cash provided by financing activities	88	304,855
Effect of exchange rate changes on cash	(69,920)	322,288
Net Decrease in Cash	(3,667,300)	(36,382)
Cash- Beginning of Period	7,374,194	1,352,130
Cash- End of Period	$ 3,706,894	$ 1,315,748

Nature and Continuance of Opera

Nature and Continuance of Operations	9 Months Ended
	Apr. 30, 2022
Nature and Continuance of Operations
1. Nature and Continuance of Operations	1. Nature and Continuance of Operations Body and Mind Inc. (the “Company”) was incorporated on 5 November 1998 in the State of Delaware, USA, under the name Concept Development Group, Inc. In May 2004, the Company acquired 100% of Vocalscape, Inc. and changed its name to Vocalscape, Inc. On October 28, 2005, the Company changed its name to Nevstar Precious Metals Inc. On October 23, 2008, the Company changed its name to Deploy Technologies Inc. (“Deploy Tech”) and, on September 15, 2010, the Company incorporated a wholly-owned subsidiary, Deploy Acquisition Corp. (“Deploy”) under the laws of the State of Nevada, USA. On September 17, 2010, the Company merged with and into Deploy under the laws of the State of Nevada. Deploy, as the surviving corporation of the merger, assumed all the assets, obligations and commitments of Deploy Tech, and we were effectively re-domiciled in the State of Nevada. Upon the completion of the merger, Deploy assumed the name “Deploy Technologies Inc.”, and all of the issued and outstanding common stock of Deploy Tech was automatically converted into and became Deploy’s issued and outstanding common stock. On 14 November 2017, the Company acquired Nevada Medical Group, LLC (“NMG”) and changed its name to Body and Mind Inc. The Company is now a supplier and grower of medical and recreational cannabis in the state of Nevada, and has retail operations in California, Ohio, and Arkansas. Principles of Consolidation These consolidated financial statements include the financial statements of the Company and its subsidiaries as follows: Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100% 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100% 14 November 2017 NMG Long Beach LLC (“NMG LB”) California, USA 100% 18 December 2018 NMG Cathedral City LLC California, USA 100% 4 January 2019 NMG San Diego LLC (“NMG SD”) California, USA 60% 30 January 2019 NMG Ohio LLC (“NMG Ohio”) Ohio, USA 100% 27 April 2017 NMG OH 1, LLC (“NMG OH 1”) Ohio, USA 100% 29 January 2020 NMG OH P1, LLC (“NMG OH P1”) Ohio, USA 100% 29 January 2020 NMG MI 1, Inc. (“NMG MI 1”) Michigan, USA 100% 24 June 2021 NMG MI C1 Inc. Michigan, USA 100% 24 June 2021 NMG MI P1 Inc. Michigan, USA 100% 24 June 2021 Canopy Monterey Bay, LLC (“Canopy”) California, USA 80%* 1 December 2021 ___________ * Represents the Company’s controlling interest (see Note 11). The Company is yet to close its acquisition and does not have a legal ownership. All inter-company transactions and balances are eliminated upon consolidation.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Apr. 30, 2022
Recent Accounting Pronouncements
2. Recent Accounting Pronouncements	2. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Apr. 30, 2022
Significant Accounting Policies
3. Significant Accounting Policies	3. Significant Accounting Policies The following is a summary of significant accounting policies used in the preparation of these consolidated financial statements. Basis of presentation These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. In the opinion of management, the unaudited consolidated interim financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s fiscal year 2021 Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on 19 November 2021. Amounts receivable Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 30 April 2022 and 31 July 2021, the Company has no allowance for doubtful accounts. Revenue recognition The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered cash on delivery. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 17 for revenue disaggregation table. Inventory Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As of 30 April 2022 and 31 July 2021, the Company has no allowance for inventory obsolescence. Loans receivable The Company carries its loans receivable at cost and are reviewed for indicators of impairment at least annually. Property and equipment Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease Intangible assets Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years, licenses acquired by Canopy have a finite life of 10 years and are amortized over these estimated useful lives on a straight-line basis. Goodwill Goodwill represents the excess of the aggregate purchase price paid over the fair value of the net assets acquired in our business combinations. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Events or changes in circumstances that could trigger an impairment review include a significant adverse change in business climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes in the manner of our use of the acquired assets or the strategy for our overall business, significant negative industry or economic trends, or significant underperformance relative to expected historical or projected future results of operations. The Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, additional impairment testing is not required. The Company tests for goodwill impairment annually during its fourth quarter on 31 July. Income taxes Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. Basic and diluted net loss per share The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Potentially dilutive options of 9,253,000 and warrants of 17,215,284 existed at 30 April 2022. This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by 1 June 2022, or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until 19 July 2025. Comprehensive loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 30 April 2022 and 31 July 2021, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements. Foreign currency translation The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.7755 for monetary assets and liabilities and 0.7916 as an average rate for transactions occurred during the period ended 30 April 2022. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss. Stock-based compensation The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur. Fair value measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The convertible loan receivable was valued using Level 3 inputs. Other current financial assets and current financial liabilities have fair values that approximate their carrying values. Use of estimates and assumptions The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities, if any, at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates. Lease accounting Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment.

Financial Instruments

Financial Instruments	9 Months Ended
	Apr. 30, 2022
Financial Instruments
4. Financial Instruments	4. Financial Instruments The following table represents the Company’s assets that are measured at fair value as of 30 April 2022 and 31 July 2021: As of 30 April 2022 As of 31 July 2021 Financial assets at fair value Cash $ 3,706,894 $ 7,374,194 Convertible loan receivable 1,893,252 1,648,816 Total financial assets at fair value $ 5,600,146 $ 9,023,010 Management of financial risks The financial risk arising from the Company’s operations include credit risk, liquidity risk, interest rate risk and currency risk. These risks arise from the normal course of operations and all transactions undertaken are to support the Company’s ability to continue as a going concern. The risks associated with these financial instruments and the policies on how to mitigate these risks are set out below. Management manages and monitors these exposures to ensure appropriate measures are implemented on a timely and effective manner. Credit risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company reduces its exposure to credit risk by maintaining its cash with major financial institutions. Credit risk associated with the convertible loans receivable arises from the possibility that the principal and/or interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationship. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company ensures, as far as reasonably possible, that it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company’s holdings of cash. The Company had working capital of $2,422,715 at 30 April 2022. The Company anticipates that current cashflow positive operations, cash on hand and working capital will ensure coverage for all expenses associated with current operations for at least the next 15 months from the issuance of these financial statements. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth of the company. Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as it does not hold financial instruments that will fluctuate in value due to changes in interest rates. Currency risk Currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company is exposed to currency risk by incurring expenditures and holding assets denominated in currencies other than its functional currency.

Inventory

Inventory	9 Months Ended
	Apr. 30, 2022
Inventory
5. Inventory	5 . Inventory 30 April 2022 31 July 2021 Work in progress $ 610,030 $ 503,215 Finished goods 3,594,580 1,547,493 Consumables 115,294 885,448 Total $ 4,319,904 $ 2,936,156

Convertible loan receivable

Convertible loan receivable	9 Months Ended
	Apr. 30, 2022
Convertible loan receivable
6. Convertible loan receivable	6 . Convertible loan receivable Effective March 15, 2019, the Company, through its wholly owned subsidiaries, DEP Nevada and NMG, entered into a convertible loan agreement and a management agreement with Comprehensive Care Group LLC (“CCG”), an Arkansas limited liability company, with respect to the development of a medical cannabis dispensary facility in West Memphis, Arkansas. The convertible loan agreement can be extended by either party and the current agreement has a maturity date of 30 March 2023. Under no circumstances the maturity date of the convertible loan agreement shall extend beyond the expiration of the management agreement as described below. Pursuant to the management agreement, NMG will provide operations and management services, including management, staffing, operations, administration, oversight, and other related services. Under the management agreement, NMG will be required to obtain approval from CCG for any key decisions as defined in the agreement and accordingly the Company does not control CCG. NMG will be paid a monthly management fee equal to 66.67% of the monthly net profits of CCG, subject to conversion of the convertible loan as discussed below upon which the monthly management fee shall be $6,000 per month, unless otherwise agreed by the parties in writing. The management agreement has an expiration of 15 March 2024 and can be mutually extendable. The convertible loan agreement is for an amount up to $1,250,000 from DEP to CCG with proceeds to be used to fund construction of a facility, working capital and initial operating expenses. The loan bears interest at a fixed rate of $6,000 per month until the parties mutually agree to increase the interest. Upon the latter of one year of granting of a medical cannabis dispensary license by the appropriate authorities or one year after entering into the convertible loan agreement, DEP may elect to convert the loan into preferred units of CCG equal to 40% of all outstanding units of CCG, subject to approval of the Arkansas Medical Marijuana Commission. The Company evaluated the convertible loan receivable’s settlement provisions and elected the fair value option in accordance with ASC 825 “Financial Instruments”, to value this instrument. Under such election, the loan receivable is measured initially and subsequently at fair value, with any changes in the fair value of the instrument being recorded in the consolidated financial statements as a change in fair value of the financial instruments. The Company estimates the fair value of this instrument by first estimating the fair value of the straight debt portion, excluding the embedded conversion option, using a discounted cash flow model. The Company then estimates the fair value of the embedded conversion option using the Black-Scholes Option Pricing Model. The sum of these two valuations is the fair value of the loan receivable balance of $1,893,252. Management believes that the accretion of the straight debt portion and embedded derivative related to the conversion option are not material due to the short term maturity of the loan. At 30 April 2022, the Company had advanced $1,893,252 (31 July 2021 - $1,648,816) and accrued interest income of $18,000 (2021 - $18,000) and $54,000 (2021 - $54,000) for the three and nine months ended 30 April 2022, respectively. As of 30 April 2022, total interest receivable was $204,000 (31 July 2021 - $150,000).

Loan receivable

Loan receivable	9 Months Ended
	Apr. 30, 2022
Loan receivable
7. Loan receivable	7 . Loan receivable The loan receivable at 30 April 2022 in the amount of $239,834 (31 July 2021 – $239,834) acquired from NMG LB (Note 11) is due from an arm’s length party that is unsecured, non-interest bearing and due on demand.

Investment in NMG Ohio LLC

Investment in NMG Ohio LLC	9 Months Ended
	Apr. 30, 2022
Investment in NMG Ohio LLC
8. Investment in NMG Ohio LLC	8. Investment in NMG Ohio LLC On 7 June 2018, the Company acquired a 30% interest in NMG Ohio, which had a cannabis dispensary and a provisional production license. On 31 January 2019, the Company entered into a definitive agreement (“Definitive Agreement”) to acquire 100% ownership of NMG Ohio, or the remaining 70% interest for total cash payments of $1,575,000 and issuance of 3,173,864 common shares of the Company. On 17 September 2021, the Company closed the acquisition of the remaining 70% interest in NMG Ohio. The transaction included the transfer of a dispensary license for the Clubhouse Dispensary in Elyria, Ohio to our wholly owned subsidiary, NMG OH 1, which became effective on 4 September 2020 (see Acquisition of the Clubhouse Dispensary in Note 11). The transaction also included the final award of a production license which has now been transferred to our wholly owned subsidiary, NMG OH P1. As a result of the closing of this acquisition, the Company now directly owns 100% of NMG Ohio. The following table is a representation of amounts advanced, the majority of which is property and equipment, which has been reclassified as assets. 30 April 2022 31 July 2021 Loan receivable (payable) to NMG Ohio Opening balance $ 891,279 $ (466,495 ) Advances provided to NMG Ohio 64,598 1,120,015 Foreign exchange - 4,671 Transferred to NMG OH 1 and reclassified to respective net assets acquired (955,877 ) 233,088 Loan receivable from NMG Ohio $ - $ 891,279

Investment in and advances to G

Investment in and advances to GLDH	9 Months Ended
	Apr. 30, 2022
Investment in and advances to GLDH
9. Investment in and advances to GLDH	9. Investment in and advances to GLDH On 3 July 2019, the Company entered into the following agreements with GLDH and other third parties: 1. a definitive asset purchase agreement (the “Purchase Agreement”) between the Company’s wholly owned subsidiary, NMG LB, GLDH and Airport Collective, Inc. to acquire 100% ownership interest in GLDH’s Long Beach, California dispensary. The Purchase Agreement was executed under the following terms: The purchase price is USD$6,700,000 (the “Purchase Price”). The consideration under the Purchase Agreement includes the following on closing: i. The USD$5,200,000 Note and accrued interest; and ii. USD$1,500,000 to be paid in common shares of the Company at a price of CAD$0.7439 per common share to a maximum of 2,681,006 common shares (the “Share Payment”) (issued) (Note 16) upon NMG LB receiving the transfer of all licenses, permits and BCC authorizations for NMG LB to conduct medical and adult-use commercial cannabis retail operations. The Share Payment is subject to reduction equal to the net liability of GLDH and Airport Collective. The Share Payment reduction is pending and, as a result, the related shares have not been released from escrow. 2. a settlement agreement (“NMG SD Settlement Agreement”) between the Company and its subsidiaries, and GLDH and its subsidiaries, to acquire a 60% ownership interest in GLDH’s San Diego, California dispensary. The NMG SD Settlement Agreement’s consideration includes the following on closing: i. USD$500,000 to be paid in common shares (624,380 common shares issued) (Note 16) to SGSD at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the settlement agreement; ii. USD$750,000 to be paid in common shares (issued) (Note 16) to Barakett at a price of CAD$0.7439 per common share to a maximum of 1,340,502 Common Shares (the “DB Share Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct medical commercial cannabis retail operations; and iii. USD$750,000 to be paid in common shares (issued) (Note 16) to Barakett at a price of CAD$0.7439 per common share to a maximum of 1,340,502 common shares (the “DB Additional Shares Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct adult-use commercial cannabis retail operations. 3. a lease assignment (the “Lease Assignment Agreement”) on the San Diego operation between the Company’s 60%-owned subsidiary, NMG SD, Green Road, LLC, Show Grow San Diego, LLC (“SGSD”), and SJJR LLC. The Lease Assignment Agreement was executed under the following terms: The Company is required to issue cash and share payments to the landlord as follows: i. USD$700,000, payable in common shares (1,031,725 common shares issued) (Note 16) at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the assignment agreement; ii. USD$783,765, payable in cash (paid), within 5 business days following execution of the assignment agreement (paid); and In April 2020, the Company fulfilled all obligations under the NMG SD Settlement Agreement and the Lease Assignment Agreement and completed the acquisition of a 60% owned dispensary located in San Diego (the “SD Transaction”). The SD Transaction was accounted for as an asset acquisition. The Company acquired the rights to an existing lease that was zoned for use as a cannabis dispensary. The Company owns the dispensary through a 60% owned subsidiary, NMG SD. The Company consolidated 100% of the assets, liabilities and the operations of NMG SD with 40% disclosed as a non-controlling interest. Additionally: 1. The Company is to provide a loan to GLDH in the amount of USD$200,000 at an interest rate of 12% per annum, accrued and compounded quarterly and due within 3 years (provided); 2. The Company is to enter into a consulting agreement with Barakett through NMG LB to provide certain consulting and advisory services to NMG LB, agreeing to pay Barakett a total of USD$200,000 ($50,000 paid in fiscal 2019 and additional $150,000 paid during the year ended 31 July 2020); 3. The Company will forgive approximately USD$800,000 for prior operating loans advanced by the Company to GLDH; and; 4. The Company licenses certain intellectual property from Green Light District Management, LLC and GLDH (collectively referred to as “Licensor”). The Licensor grants the Company a perpetual license to utilize its operational intellectual property consisting of customer data, sales data, customer outreach strategies standard operating procedures, and other proprietary operational intellectual property. Licensor grants the Company a license for 2 years to utilize intellectual property such as trademarks and branding (the “Branding IP”). As consideration for the licenses, the Company has agreed to utilize the Branding IP until 19 June 2021 at the Company’s premises and at the San Diego retail locations for a period of 2 years from operations commencing at that location. Additionally, the Company agreed to pay the Licensor 3% of gross receipts from sales at the Long Beach dispensary. The Company’s total investment in GLDH was as follows: Note receivable $ 5,200,000 Share issuances 4,092,175 Share payment reduction (793,416 ) Interest income accrued on the Note 1,821,476 Advances for working capital 2,813,515 Lease Assignment Agreement payment 1,533,765 Amount transferred to Property and Equipment (1,431,585 ) Amount transferred to Brand and Licenses (3,585,483 ) Expensed during the year (690,741 ) Foreign exchange (46,973 ) Balance – 31 July 2020 8,912,733 Impairment loss (534,165 ) Acquisition of ShowGrow Long Beach dispensary (Note 11) – 28 August 2020 $ (8,378,568 )

Property and Equipment

Property and Equipment	9 Months Ended
	Apr. 30, 2022
Property and Equipment
10. Property and Equipment	10. Property and Equipment Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2021 $ 401,571 $ 466,110 $ 570,702 $ 51,108 $ 38,717 $ 10,335 $ 5,055,799 $ 6,594,342 Additions 57,951 - - 11,994 - - 1,437,163 1,507,108 Balance, 30 April 2022 459,522 466,110 570,702 63,102 38,717 10,335 6,492,962 8,101,450 Accumulated Depreciation: Balance, 31 July 2021 49,765 250,544 210,166 21,722 24,328 1,790 1,142,237 1,700,552 Depreciation 45,687 51,094 58,827 6,101 4,137 1,104 542,291 709,241 Balance, 30 April 2022 95,452 301,638 268,993 27,823 28,465 2,894 1,684,528 2,409,793 Net Book Value: At 31 July 2021 351,806 215,566 360,536 29,386 14,389 8,545 3,913,562 4,893,790 At 30 April 2022 $ 364,070 $ 164,472 $ 301,709 $ 35,279 $ 10,252 $ 7,441 $ 4,808,434 $ 5,691,657 For the nine months ended 30 April 2022, a total depreciation of $152,317 (2021 - $56,934) was included in General and Administrative Expenses and a total depreciation of $556,924 (2021 - $322,109) was included in Cost of Sales.

Business Acquisitions

Business Acquisitions	9 Months Ended
	Apr. 30, 2022
Business Acquisitions
11. Business Acquisition	11 . Business Acquisitions The Clubhouse dispensary On 4 September 2020, NMG OH 1 received all approvals and final license and name transfer from the Ohio Department of Pharmacy for Clubhouse dispensary located in Elyria, Ohio. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The acquisition of The Clubhouse dispensary allows the Company to expand into the State of Ohio. This acquisition was the first part of the acquisition of the remaining 70% interest in NMG Ohio. The remaining production licenses were transferred to NMG OH P1 in the asset acquisition (Note 8) resulting in the completion of the acquisition of NMG Ohio. The following table summarizes the fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of NMG OH 1 made by the Company: Purchase consideration $ 3,814,788 Assets acquired: Cash 257,462 Amounts receivable 510,367 Prepaid expenses 4,965 Inventory 178,898 Property and equipment 763,951 Licenses and customer relationships 2,710,000 Liabilities assumed: Trade payable and accrued liabilities 443,589 ) Net assets acquired 3,982,054 Bargain purchase (167,266 ) TOTAL $ 3,814,788 ShowGrow Long Beach dispensary On 28 August 2020, NMG LB received all approvals and final license transfer for the ShowGrow Long Beach dispensary (as further discussed in Note 9). The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The acquisition of ShowGrow Long Beach dispensary allows the Company to enter the California market. The following table summarizes the fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of NMG LB made by the Company: Purchase consideration $ 8,378,568 Assets acquired: Cash 65,340 Prepaid expenses 15,264 Inventory 177,930 Property and equipment 5,402 Loan receivable (Note 7) 239,834 Liabilities assumed: Trade payable and accrued liabilities (732,262 ) Income taxes payable (423,931 ) Loans payable (Note 14) (12,910 ) Net assets acquired (664,613 ) Brand and licenses 6,510,000 Goodwill 2,533,181 TOTAL $ 8,378,568 Canopy Monterey Bay, LLC On November 30, 2021, the Company entered into two definitive agreements with Canopy Monterey Bay, LLC (“Canopy”) and the membership interest owners (the “Sellers”) of Canopy to acquire an aggregate of 100% of Canopy, which owns a retail dispensary in the limited license jurisdiction of Seaside, California, to expand retail operation. The first purchase agreement (“PA #1”) between DEP and Canopy and all of the Sellers provides for the assignment of 80% of the membership interests of Canopy to DEP in exchange for a purchase price of $4,800,000 comprised of $2,500,000 in cash (the “Cash Purchase Price”) and a secured promissory note in the amount of $2,300,000 bearing interest at a rate of 10% per annum compounded annually and having a maturity date of five years from the effective date of PA #1. Interest is payable for the first 6 months with the principal and accrued interest due at maturity. There are no prepayment penalties. The Cash Purchase Price is to be paid into escrow pursuant to an escrow agreement between the parties to PA #1 and Secured Trust Escrow, which Cash Purchase Price is to be released to the Sellers upon the receipt of city and state approval and completion of the audited annual financial statements and unaudited interim reviewed financial statements (collectively, the “Financial Statements”) of Canopy, or returned to DEP in the event of the denial of city or state approval or failure to complete the Financial Statements and the agreement is terminated, in which case the 80% membership interests will be transferred back to the Sellers and the promissory note will automatically be terminated. As of the date hereof, the city and state approvals have been received and the formal closing of the purchase of the 80% of the membership interests in Canopy is expected to take place on the date following the completion of the Financial Statements. The second purchase agreement (“ PA #2 Consideration Shares VWAP Additional Shares On or around December 1, 2021, 80% of the membership interests of Canopy were transferred to DEP for purposes of applying for city and state approvals of the change in ownership of Canopy, however, the purchase price consideration of (i) $2.5 million in cash, and (ii) a promissory note in the amount of $2.3 million to be paid by DEP, were placed in escrow and not to be released to the sellers of the 80% membership interests in Canopy until the city and state approvals have been received and the audited annual financial statements and unaudited reviewed interim financial statements (collectively, the “Financial Statements”) of Canopy are completed. If the city or state approvals are not received, or the Financial Statements of Canopy are not completed, then the Buyer may terminate the membership interest purchase agreement requiring the membership interests in Canopy to be transferred back to the sellers and the escrow agent to deliver back to DEP the cash consideration and the promissory note shall automatically be terminated. As of the date hereof, the city and state approvals have been received and the formal closing of the purchase of the 80% membership interests in Canopy will take place on the date following the completion of the Financial Statements. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. For accounting purposes, the acquisition date is the date that the Company obtained full control over the operations, although not all conditions for closing the acquisition had occurred as of 1 December 2021. The purchase accounting process has not been completed primarily because the valuation of acquired assets has not been finalized. We expect to complete the purchase accounting as soon as practicable but no later than one year from the acquisition date. The following table summarizes the preliminary estimated fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of Canopy made by the Company: Purchase consideration Cash $ 2,500,000 Promissory note 2,300,000 Shares of common stock (Note 16) 939,544 Total consideration – preliminary 5,739,544 Assets acquired: Cash – preliminary 378,503 Inventory – preliminary 630,039 Liabilities assumed: Trade payable and accrued liabilities – preliminary (317,594 ) Net assets acquired – preliminary 690,948 Brand and licenses – preliminary 4,270,000 Goodwill – preliminary 778,596 TOTAL $ 5,739,544 Pro Forma The following table summarizes the results of operations of The Clubhouse Dispensary and NMG LB since the acquisition dates included in the Company’s consolidated results of operations for the nine months ended 30 April 2022: The Clubhouse Dispensary NMG LB Revenue $ 6,103,097 $ 4,213,881 Net income 1,378,818 57,837 The following table summarizes our consolidated results of operations for the nine months ended 30 April 2021 as though the acquisitions of The Clubhouse Dispensary and NMG LB had occurred on 1 August 2020: Nine months ended 30 April 2021 As Reported Pro Forma (unaudited) Revenue $ 18,765,785 $ 19,843,563 Net income (loss) (2,177,189 ) 259,929 Pro forma financial information related to Canopy was deemed impractical to disclose as the final consideration and the allocation of intangible assets is still preliminary. The unaudited pro forma information set forth above is for informational purposes only and include all adjustments necessary for the fair presentation, in all material respects, of the Company’s combined operations including The Clubhouse Dispensary and NMG LB as if the business combinations occurred on 1 August 2020. No adjustments have been made to reflect potential cost savings that may occur subsequent to completion of the transactions. The unaudited pro forma financial information is not intended to reflect the results of operations of the Company which would have actually resulted had the proposed transaction been effected on the date indicated above. Further, the unaudited pro forma financial information is not necessarily indicative of the results of operations that may be obtained in the future. The actual pro forma adjustments will depend on a number of factors, and could result in a change to the unaudited pro forma financial information.

Intangible Assets Net

Intangible Assets Net	9 Months Ended
	Apr. 30, 2022
Intangible Assets Net
12. Intangible Assets, Net	12 . Intangible Assets, Net As of 30 April 2022 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 517,000 - $ - $ 517,000 Licenses 24,718,508 10.0 (2,231,921 ) 22,486,587 Customer relationships 90,000 5.0 (29,721 ) 60,279 Total intangible assets $ 25,325,508 $ (2,261,642 ) $ 23,063,866 As of 31 July 2021 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 20,718,508 10.0 (1,184,175 ) 19,534,333 Customer relationships 90,000 5.0 (16,265 ) 73,735 Total intangible assets $ 21,055,508 $ (1,200,440 ) $ 19,855,068 Amortization expense for intangible assets was $389,879 and $292,398 for the three months ended 30 April 2022 and 2021, respectively and $1,061,201 and $775,692 for the nine months ended 30 April 2022 and 2021, respectively. Included in the licenses is $7,925,000 of indefinite lived assets. The expected amortization of the intangible assets, as of 30 April 2022, for each of the next five years and thereafter is as follows: 2022 (remaining) $ 403,021 2023 1,598,943 2024 1,603,324 2025 1,598,943 2026 1,582,678 Thereafter 7,834,958 $ 14,621,867

Related Party Balances and Tran

Related Party Balances and Transactions	9 Months Ended
	Apr. 30, 2022
Related Party Balances and Transactions
13. Related Party Balances and Transactions	13. Related Party Balances and Transactions In addition to those disclosed elsewhere in these consolidated financial statements, related party transactions paid/accrued for the three and nine months ended 30 April 2022 and 2021 are as follows: For the three months ended 30 April 2022 For the three months ended 30 April 2021 For the nine months ended 30 April 2022 For the nine months ended 30 April 2021 A company controlled by the President, Chief Executive Officer and a director Management fees $ 55,429 $ 40,020 $ 228,425 $ 114,985 A company controlled by the Chief Financial Officer and a director Management fees 23,895 25,512 102,473 71,514 A company controlled by a former director and former President of NMG Management fees - 10,000 - 65,000 A company controlled by the Corporate Secretary Management fees 18,754 19,144 56,217 53,933 $ 98,078 $ 84,676 $ 387,115 $ 305,432 On November 12, 2021 the independent members of the Compensation Committee and Board of Directors of Body and Mind approved an Executive Bonus Program for FY2022 for the CEO, COO and CFO. The Board of Directors approved an incentive-based cash bonus program for CEO’s consulting company and for the COO of up to a maximum of $200,000 per CEO or COO based on the consolidated revenue performance of the Company for each quarter of the fiscal year ended July 31, 2022 compared to the prior quarter. Each of the CEO and COO could earn (i) $5,000 in cash for each 1% revenue growth over the prior quarter, and/or (ii) $10,000 in cash for each 1% Adjusted EBITDA growth over the prior quarter, all subject to a $50,000 maximum amount per executive that could be earned for each quarter of the fiscal year ended July 31, 2022. In addition, the Compensation Committee and the Board of Directors approved that they will consider a further discretionary cash bonus to the CEO’s consulting company and the COO at the fiscal year ended July 31, 2022, based on performance metrics of the Company over the course of the fiscal year ended July 31, 2022. Furthermore, on November 12, 2021, the independent members of Compensation Committee and the Board of Directors approved a cash bonus to be paid to the CFO’s consulting company up to a maximum of $40,000 based on the timing of the filing of Company’s periodic reports for the fiscal year ended July 31, 2022. The bonus consists of a quarterly bonus of $10,000 per quarter based on filing of the Company’s Form 10-Q’s and 10-K by the filing deadline, not including any extensions pursuant to Rule 12b-25 under the Exchange Act. On November 30, 2021, the independent members of Compensation Committee and Board of Directors of Body and Mind approved an Executive Bonus for FY2021 for the CEO, COO. The Compensation Committee and Board of Directors approved an aggregate of 448,000 stock options (the “Options”) in accordance with the Company’s stock option plan at an exercise price of CAD$0.44 per share for a term of five years expiring on November 30, 2026. The Options are subject to vesting provisions such that 25% of the Options vest six (6) months from the date of grant, 25% of the Options vest twelve (12) months from the date of grant, 25% of the Options vest eighteen (18) months from the date of grant and 25% of the Options vest twenty-four (24) months from the date of grant. Amounts owing to related parties at 30 April 2022 and 31 July 2021 are as follows: a) As of 30 April 2022, the Company owed $5,246 (31 July 2021 - $26,841) to the Chief Executive Officer of the Company and a company controlled by him. b) As of 30 April 2022, the Company owed $10,744 (31 July 2021 - $18,914) to the Chief Financial Officer of the Company and a company controlled by him. c) As of 30 April 2022, the Company owed $6,299 (31 July 2021 - $6,319) to the Corporate Secretary of the Company and a company controlled by him. The above amounts owing to related parties are unsecured, non-interest bearing and are due on demand.

Loan Payable

Loan Payable	9 Months Ended
	Apr. 30, 2022
Loan receivable
14. Loan Payable	14. Loans Payable On 19 July 2021, the Company entered into and closed a loan agreement (the “Loan Agreement”) with FG Agency Lending LLC (the “Agent”) and Bomind Holdings LLC (the “Lender”). Upon entering into the Loan Agreement, the Lender provided the initial term loan (the “Initial Term Loan”) in the face amount of $6,666,667 of which $6,000,000 was advanced to the Company with the 10% representing an origination discount as consideration for the use or forbearance of money. The Company may draw upon the remaining face amount of $4,444,444 (the “Delayed Draw Term Loan”) upon providing a 30-day request to the Agent by 1 June 2022 (as extended on 1 December 2021), whereby $4,000,000 will be advanced to the Company after applying the 10% origination discount. The Initial Term Loan and the Delayed Draw Term Loan mature on 19 July 2025 and bear interest at a rate of 13% per annum payable on the first day of each month hereafter. Pursuant to the Loan Agreement, the Company issued an aggregate of 8,000,000 common stock purchase warrants (each, a “Warrant”) to the Agent of which (i) 4,800,000 Warrants will entitle the holder to acquire shares of common stock (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share until July 19, 2025, and (ii) 3,200,000 Warrants will be held in escrow by us and released to the Agent at the time the Company draws on the Delayed Draw Term Loan, or cancelled if we do not draw on the Delayed Draw Term Loan, which will entitle the holder to acquire a Warrant Share at an exercise price of $0.45 per Warrant Share until July 19, 2025. Subsequent to 30 April 2022, the Company amended the Loan Agreement (Note 21). The 4,800,000 Warrants were valued at $1,037,146 using the Black Scholes Option Pricing Model using the following assumptions: Expected life of the options 4.00 years Expected volatility 139 % Expected dividend yield 0 % Risk-free interest rate 0.55 % The Company also paid agent fee, legal fees and other fees in the amount of $175,758. The Initial Term Loan is secured by certain of the Company’s assets, equity interest in subsidiaries and various agreements, under the Security Agreement, the Pledge Agreement and the Omnibus Collateral Assignment. During the nine months ended 30 April 2022, the Company recorded $356,732 related to the amortization of debt discount and $657,222 related to the interest expense. As of 30 April 2022, the remaining debt discount was $1,511,063. On 30 November 2021, the Company completed PA #1 related to the Company’s acquisition of initial 80% interest in Canopy (Note 11). In connection with PA #1, DEP entered into secured promissory note (the “Promissory Note”) promising to pay $2,300,000 to the Sellers. The Promissory Note was delivered as partial consideration for DEP’s agreement to purchase 80% of the issued and outstanding membership interests (the “Purchased Interests) of Canopy from the Sellers. The Promissory Note was signed on 30 November 2021, but does not become effective by its terms unless and until the state regulators and local regulators approve DEP as the owner of the Purchased Interests (the date such approval is received being the “Effective Date”). In the event the MIPA #1 for DEP to purchase the Purchased Interests is terminated for any reason, the Promissory Note automatically terminates.

Operating Leases

Operating Leases	9 Months Ended
	Apr. 30, 2022
Operating Leases
15. Operating Leases	15. Operating Leases a) On 10 November 2017, NMG entered into a revised five-year lease agreement for the property located at 3375 Pepper Lane, Las Vegas, NV, containing approximately 18,000 square feet. The Company has four options to extend the lease and each option is for five years. The monthly rent was $12,500 plus common area expenses, which now increased to $13,663 plus common area expenses. The guaranteed minimum monthly rent is subject to a 2% increase on each anniversary date of the lease. In April 2022, the Company signed a five-year lease extension up to November 2032. The lease payments are subject to a 3% increase annually from November 2027. b) On 9 April 2019, NMG entered into a three-year lease agreement for the property located at 6420 Sunset Corporate Drive, Las Vegas, NV, containing approximately 7,700 square feet. The Company has one option to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term. At 30 April 2022, it is expected that the extension option will be exercised by the Company. The monthly rent now increased to $6,478. c) On 24 April 2020, the Company assumed a five-year lease dated 1 December 2018, as amended on 13 June 2019, for the property located at 7625 Carroll Road, San Diego, CA. The Company has three options to extend the lease and each option is for five years. At 30 April 2022, it is expected that the first option to extend will be exercised by the Company. The monthly rent is $15,450 per month increasing by 3% every year until 1 December 2022. The rent is now $16,883. The lease contains a sale bonus provision of $1,000,000 or 10% of the purchase price of the entire business, whichever is greater, in the event of sale or assignment of the lease. d) On August 2, 2018, NMG Ohio, LLC entered into a three-year lease agreement for the property located at 709 Sugar Lane, Elyria, Ohio 44035, containing approximately 4,100 square feet. The Company has three options to extend the lease and each option is for three years. At 30 April 2022, it is expected that the Company will exercise the first and second options to extend. The rent is $4,200 per month increasing by 5% starting on 1 July 2021 and 1 July 2024. e) On 28 August 2020, the Company assumed a five-year lease dated 10 January 2017, as amended on 7 September 2018, for the property located at 3411 E. Anaheim St., Long Beach, California. The Company has one option to extend the lease for five years. The rent is $7,682 per month increasing by 3% every year until 10 January 2022. In March 2022, the Company entered into an amendment to the lease whereby the Company was granted two five-year extension options up to January 2037 subject to 5% increase in monthly rent each year. At 30 April 2022, it is expected that the Company will exercise the first option to extend. As part of the amendment, the Company signed an adjacent unit for $1,632 per month increasing by 3% every year until 10 January 2027. The adjacent unit can also be extended for two five-year options up to January 2037, subject to 3% annual increase in rent. f) On 14 September 2021, the Company assumed a three-year lease dated 1 October 2019 for the property located at 719 Sugar Lane, Elyria, Ohio (Note 8). The Company has three options to extend the lease and each option is for three years. At 30 April 2022, it is expected that the Company will exercise the first and second options to extend. The rent is $4,000 per month. g) On 23 April 2021, the Company’s subsidiary NMG MI 1 entered into a five-year lease for the property located at 885 E. Apple Ave., Muskegon, Michigan. The Company has three options to extend the lease and each option is for five years. At 30 April 2022, it is expected that the Company will exercise the first option to extend. The rent is $5,000 per month increasing by 2% every year. The lease is contingent upon NMG MI 1 receiving one or more commercial marihuana municipal licenses from the City of Muskegon. The license(s) would allow NMG MI 1 to operate a dispensary for the distribution of adult-use and/or medical marihuana and all activities permissible under the Michigan and Muskegon Marihuana Laws. The Company took possession of the property effective 1 October 2021. Upon NMG MI 1 receiving one or more licenses, NMG MI 1 agrees to cause the Company to issue common shares having a value of up to $150,000 to Kendal, with portions of the common shares to be issued upon the achievement of certain milestones as follows: i. 25% of the common shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial medical marihuana retail license from the city of Muskegon, MI and a state commercial medical marihuana retail license from the state of Michigan; ii. 25% of the common shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial medical marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin medical marihuana operations at the premises; iii. 25% of the common shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial adult-use marihuana retail license from the city of Muskegon, MI and a state commercial adult-use marihuana retail license from the state of Michigan; iv. 25% of the common shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial adult-use marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin adult-use marihuana operations at the premises; During the nine months ended 30 April 2022, the Company accrued $150,000 for milestones above and were included in the related operating lease liability. On 21 September 2021, the Company issued the necessary common shares to settle $75,000 of this liability (Note 16). The remaining $75,000 remains outstanding at 30 April 2022. On 3 March 2022, the Company’s subsidiary, NMG MI 1, Inc. entered into an Amendment No. 1 to Lease Agreement with Kendal Properties, LLC with respect to the premises located at 885 E. Apple Ave., Muskegon, Michigan, whereby the parties amended the original Lease Agreement to provide that two of the milestone payments that were to be made in the form of the Company’s shares are to now be made in the form of cash h) On 10 February 2020, the Company’s subsidiary NMG MI C1 executed a lease agreement with 254 River Street LLC (“River Street”) to lease commercial space located at 254 River Street, Manistee, MI, 49660. The term of the lease is for a period of 60 months and the lease includes rent abatement and reduced rent periods during construction and start up. Final rent is approximately US$22,500 per month and is contingent upon NMG MI C1 receiving one or more commercial marihuana municipal licenses from the City of Manistee. The license(s) would allow NMG MI C1 to operate a cultivation facility for adult use and/or medical marihuana and all activities permissible under the Michigan and Manistee Marihuana Laws. Upon NMG MI C1 receiving one or more Licenses, NMG MI C1 agrees to cause the Company to issue common shares having a value of up to $600,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of common shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana cultivation licenses; ii. US$200,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to cultivation and receiving local operating permit to begin commercial marihuana cultivation operations at the premises; iii. US$100,000 of common shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana retail licenses; and iv. US$100,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to retail operations and receiving local operating permit to begin commercial marihuana retail operations at the premises. At 31 July 2021, the Company accrued $200,000 for milestone (i) above. On 21 September 2021, the Company issued the necessary common shares to settle this $200,000 liability (Note 16). During the nine months ended 30 April 2022, the Company accrued an additional $200,000 and were included in the related operating lease liability for milestone (ii) above. Milestones (iii) and (iv) have not yet been achieved at of 30 April 2022. i) On 10 February 2020, the Company’s subsidiary NMG MI P1 executed a lease agreement with 254 River Street LLC (“River Street”) to lease commercial space located at 254 River Street, Manistee, MI, 49660. The term of the lease is for a period of 60 months and the lease includes rent abatement and reduced rent periods during construction and start up. Final rent is approximately US$7,500 per month, which increases 2% annually, and is contingent upon NMG MI P1 receiving one or more commercial marihuana municipal licenses from the City of Manistee. The license(s) would allow NMG MI P1 to operate a production facility for adult-use and/or medical marihuana and all activities permissible under the Michigan and Manistee Marihuana Laws. Upon NMG MI P1 receiving one or more Licenses, NMG MI P1 agrees to cause the Company to issue common shares having a value of up to $400,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of common shares to be issued within 30 days of NMG MI P1 receiving local and state commercial marihuana processing licenses; and ii. US$200,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to processing and receiving local operating permit to begin commercial marihuana processing operations at the premises. At 31 July 2021, the Company accrued $200,000 for milestone (i) above. On 21 September 2021, the Company issued the necessary common shares to settle this $200,000 liability (Note 16). During the nine months ended 30 April 2022, the Company accrued an additional $200,000 and were included in the related operating lease liability for milestone (ii) above, which has not yet been achieved as of 30 April 2022. During the nine months ended 30 April 2022, a total deposit $470,546 for prior year shares were reclassified and incorporated into the right-of-use asset and lease liabilities related to the Company’s leases for the River Street. The value of the common shares will be calculated based on the lesser of: (1) the closing market price on the respective milestone achievement date and (2) a ten percent discount to the twenty-day volume weighted average price for the twenty days immediately prior to the respective milestone achievement date(s). Leases for 254 River St., Manistee, Michigan 49660 and 885 E. Apple Ave., Muskegon, Michigan 49442 were subject to the Company subsidiaries receiving approval by the State of Michigan and could be cancelled by the Company if licences were not awarded. The licenses for NMG MI P1 and NMG MI C1 were issued on 19 July 2021 and license for NMG MI 1 was issued on 3 August 2021. j) On 1 January 2020, the Company’s subsidiary Canopy entered into a three-and-a-half-year lease agreement for the property located in Seaside, California. The rent is now $9,000 per month until June 2023. During the nine months ended 30 April 2022, the Company recorded a total lease expense of $709,561 related to the accretion of lease liabilities and the amortization of right-of-use assets of which $600,178 was included in General and Administrative Expenses and $109,383 was included in Cost of Sales for the nine months ended 30 April 2022. Supplemental cash flow information related to leases was as follows: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 583,427 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 3,896,652 Weighted-average remaining lease term – operating leases 7.88 years Weighted-average discount rate – operating leases 12 % The discount rate of 12% was determined by the Company as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Maturities of lease liabilities were as follows: Year Ending 31 July Operating Leases 2022 (remaining) $ 275,399 2023 1,542,189 2024 1,101,214 2025 1,157,278 2026 and thereafter 5,162,344 Total lease payments $ 9,241,424 Less imputed interest (3,270,643 ) Total $ 5,970,781 Less current portion (886,202 ) Long term portion $ 5,084,579 The Company has entered into two lease agreements for operations with terms similar to current lease agreements that are not yet effective, as certain conditions required have not yet occurred. The Company paid a deposit of $107,290 during the period ended 30 April 2022 recorded in Deposits on the balance sheet.

Capital Stock

Capital Stock	9 Months Ended
	Apr. 30, 2022
Capital Stock
16. Capital Stock	16. Capital Stock The Company’s authorized share capital comprises 900,000,000 Common Shares, with a $0.0001 par value per share. On 21 October 2020, the Company issued 793,466 common shares valued at $297,042 in relation to acquiring the remaining 70% interest in NMG Ohio. On 21 September 2021, the Company issued 238,929 common shares to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises and issued an aggregate of 1,304,601 common shares to another entity based on the terms and conditions of the two lease agreements for the Manistee, Michigan premises (Notes 15 and 18). Pursuant to the ShowGrow Long Beach Purchase Agreement (Note 9), the Company issued 2,681,006 common shares in escrow. The share consideration remains subject to reduction with reference to the liabilities of the business that will be outstanding on the closing date, which is expected to occur in the near future (Notes 11 and 19). Pursuant to the PA #2 for the acquisition of Canopy’s membership interest, the Company issued 2,728,156 common shares on 3 December 2021 in escrow (Notes 11 and 18). Stock options The Company previously approved an incentive stock option plan, pursuant to which the Company may grant stock options up to an aggregate of 10% of the issued and outstanding common shares in the capital of the Company from time to time. Under this plan, the Company may issue up to 11,334,946 stock options. At 30 April 2022, the Company had 9,253,000 stock options issued and outstanding. The Company recorded total stock-based compensation expense of $91,383 (2021 - $244,276) and $386,327 (2021 - $733,098) for the three and nine months ended 30 April 2022 and 2021, respectively, in connection with the issuance of options to purchase common stock. Stock-based compensation expense is included in general and administrative expenses on the accompanying statements of operations. Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2021 9,855,000 CAD$0.70 2.30 CAD$ - Granted 648,000 CAD$0.44 3.97 CAD$ - Cancelled (1,250,000 ) CAD$0.70 0.92 CAD$ - Outstanding at 30 April 2022 9,253,000 CAD$0.69 2.30 CAD$ - Vested and fully exercisable at 30 April 2022 8,180,000 CAD$0.70 2.05 CAD$ - On 30 November 2021, the Company granted 448,000 stock options to two officers and directors of the Company with an exercise price of CAD$0.44 per share expiring on 30 November 2026. These stock options vest equally every 6 months for a period of 24 months. On 30 November 2021, the Company granted 200,000 stock options to a consultant of the Company with an exercise price of CAD$0.44 per share expiring on 30 November 2024 (Note 19). These stock options vest immediately. Share Purchase Warrants As of 30 April 2022 and 31 July 2021, the following warrants are outstanding: Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 4,800,000 USD$0.40 19 July 2025 17,215,284 (1) ______________--- (1) This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by 1 June 2022 (extended, see Note 21), or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025

Segmented Information and Major

Segmented Information and Major Customers	9 Months Ended
	Apr. 30, 2022
Segmented Information and Major Customers
17. Segmented Information and Major Customers	17. Segmented Information and Major Customers In its operation of the business, management, including our chief operating decision marker, who is also our Chief Executive Officer, reviews certain financial information, including segmented internal profit and loss statements prepared on a basis not consistent with GAAP. During the periods presented, the Company reported its financial performance based on the following segments: · Wholesale; · Retail; and · All others Revenue and costs are generally directly attributed to our segments. However, due to the integrated structure of our business, certain costs incurred by one segment may benefit other segments. In addition, certain costs incurred at a corporate level are not allocated to our segments. Segment revenue and net loss were as follows during the nine months ended 30 April 2022: 30 April 2022 Revenue Wholesale $ 4,303,780 Retail 19,190,236 Total $ 23,494,016 Net income (loss) before income taxes Wholesale $ 208,574 Retail 1,932,547 All others (5,063,888 ) Total $ (2,922,766 ) During the nine months ended 30 April 2022, the Company had no major customer over 10% of its revenues.

Supplemental Disclosures with R

Supplemental Disclosures with Respect to Cash Flows	9 Months Ended
	Apr. 30, 2022
Supplemental Disclosures with Respect to Cash Flows
18. Supplemental Disclosures with Respect to Cash Flows	18. Supplemental Disclosures with Respect to Cash Flows Nine Months Ended 30 April 2022 2021 Cash paid during the period for interest $ 657,222 $ - Cash paid during the period for income taxes $ 1,075 $ 49,146 Pursuant to certain licensing milestones being achieved under a lease agreement for a premises in Muskegon, Michigan and certain licensing and operational milestones being achieved under two lease agreements for a premises in Manistee, Michigan, on 21 September 2021, the Company issued 238,929 shares of common stock to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises and issued an aggregate of 1,304,601 shares of common stock to another entity based on the terms and conditions of the two lease agreements for the Manistee, Michigan premises (Notes 15 and 16). On the assumption of an additional leases in Ohio and Michigan and lease amendments in Nevada and Long Beach (Note 15), the Company recognized right-of-use assets, and a corresponding increase in lease liabilities, in the amount of $3,896,652 which represented the present value of future lease payments using a discount rate of 12% per annum. Pursuant to the PA #2 for the acquisition of Canopy’s membership interest, the Company issued 2,728,156 common shares in escrow (Notes 11 and 16).

Commitments

Commitments	9 Months Ended
	Apr. 30, 2022
Commitments
19. Commitments	19. Commitments In connection with the strategic investment agreement with Australis dated 30 October 2018 (the “Investment Agreement”) (Note 20), the Company agreed to pay a monthly service fee of $10,000 to Australis. In connection with the Company’s investment in GLDH and the promissory note provided by Australis, the Company agreed to increase the monthly services fee to Australis to $16,500 per month for 5 years unless ownership held by Australis drops below 10% in which the fee will cease. Following the repayment of the promissory note, the monthly service fee to Australis was reduced to $12,000 commencing June 2019. In September 2021, Australis sold 9,900,000 of our restricted common shares in a private transaction which resulted in Australis’ beneficial ownership dropping below 10% of our outstanding common shares. As a result of Australis’ beneficial ownership falling below 10%, the Investment Agreement was terminated and monthly commercial advisory and consulting fees paid from the Company to Australis were terminated along with Australis’ entitlement to nominate a director to the board of directors of our Company. During the nine months ended 30 April 2022, pursuant to the ShowGrow Long Beach Purchase Agreement (Note 9), the Company issued 2,681,006 common shares in escrow. The share consideration remains subject to reduction with reference to the liabilities of the business that will be outstanding on the closing date, which is expected to occur in the near future. Any final settlement that is different than liabilities’ balances currently recorded will be allocated to other income or expense. During the nine months ended 30 April 2022, the Company signed a consulting agreement with Skanderbeg Capital Advisors Inc. to provide capital market advisory services, including introductions to prospective investors and merger and acquisition transactions and advising on capital structuring and other financial aspects of financings or strategic transactions. Skanderbeg Capital Advisors is a boutique merchant bank and capital advisor firm, which is focused on identifying companies with highly prospective business opportunities in the natural resource, technology, biotech and special situations sectors. The Company will pay a monthly fee of CAD$7,500 and a one-time payment of 200,000 options priced at CAD$0.44 (Note 16).

Other Agreements

Other Agreements	9 Months Ended
	Apr. 30, 2022
20. Other Agreements	20. Other Agreements On 6 August 2021, the Company entered into management agreements with each of NMG IL 1, LLC (“NMG IL 1”) and NMG IL 4, LLC (“NMG IL 4”) along with an option to indirectly acquire all of the membership interests in each of NMG IL 1 and NMG IL 4 pursuant to a convertible credit facility between our subsidiary, DEP and each of NMG IL 1 and NMG IL 4, and membership interest purchase agreements between DEP and the members of NMG IL 1 and NMG IL 4, subject to obtaining all required local and state regulatory authorization. Each of NMG IL 1 and NMG IL 4 have been identified in the Illinois Department of Financial and Professional Regulation (IDFPR) results of the Social Equity Justice Involved Lottery for 55 Conditional Adult-Use Cannabis Dispensary Licenses (Conditional Licenses) across the state. The certified results are from a lottery with a pool of applicants who scored 85 % or greater in their applications. NMG IL 1 and NMG IL 4 were drawn in BLS Region #5 (Chicago-Naperville-Elgin) where 36 conditional licenses are available. The applications are not tied to specified locations.

Subsequent Events

Subsequent Events	9 Months Ended
	Apr. 30, 2022
Subsequent Events
21. Subsequent Events	21. Subsequent Events The Company signed a lease agreement, effective 1 June 2022, for an office space located in Henderson, Nevada. The lease is for 3 years for $4,482 per month. On 15 June 2022, the Company entered into a second amendment to the Loan Agreement (“Amendment No. 2 to Loan Agreement”) (Note 14) to extend the maturity date by one year to 19 July 2026. Additionally, Amendment No. 2 to Loan Agreement allows the outside date for the Company to draw on the delayed draw term loan of US$4.44 million to be extended from June 1, 2022 to March 31, 2023, whereby US$4 million in funds will be advanced to the Company. The ability of the Company to draw on the delayed draw term loan is subject to compliance with certain provisions in Loan Agreement including provision of a satisfactory budget approved at the sole discretion of the Lender. The Amendment No. 2 to Loan Agreement increases the interest rate on the advanced funds from 13% to 15% per annum, which additional 2% interest may be paid in kind, with the interest being payable on the first day of each month. Amendment No. 2 to Loan Agreement provides for an exit fee equal to 1.5% of the principal balance, which is due and payable upon any payment, in part or in full, of the initial term loan and the delayed draw term loan. As partial consideration for Amendment No. 2 to Loan Agreement, the Company has issued 1,000,000 common stock purchase warrants (each, a “Warrant”) to the Lender. Each Warrant entitles the holder to acquire one share of common stock (each, a “Warrant Share”) at an exercise price of US$0.16 per Warrant Share until June 14, 2027. On 17 June 2022, the Company, through its wholly owned subsidiary, DEP Nevada, Inc., entered into the first amendment to PA #1 and PA #2 (the “First Amendment”) whereby the cash purchase price under PA #1 will be reduced from US$2.5 million to US$1.25 million and the Company will issue US$1.25 million shares of common stock of the Company to the Sellers based on the 10 day volume weighted average price (“VWAP”) for the ten (10) consecutive trading days prior to the effective date of the First Amendment (the “Effective Date”) and subject to compliance with the policies of the Canadian Securities Exchange (the “CSE”). The Company will also issue additional shares to Cary Stiebel equal to the difference between the amount of the shares of common stock of the Company that were issued by the Company to Mr. Stiebel on December 3, 2021 (the “PA #2 Shares”) and the amount of shares that Mr. Stiebel would have received had the VWAP for the PA #2 Shares been calculated as of the Effective Date (the “Additional PA #2 Shares”). Additionally, on the date that is eighteen (18) months (548 days) following the Effective Date of this First Amendment (the “Additional Share Issuance Date”) the Company will issue US$100,000 worth of shares to the Sellers based on the ten (10) day VWAP and subject to compliance with the policies of the CSE, calculated as of the Additional Share Issuance Date. Furthermore, DEP shall cause the Company to issue to Mr. Stiebel Three Hundred Thousand Dollars (US$300,000.00) worth of shares of common stock of the Company within three (3) days following the Effective Date of this First Amendment, which shall be priced at the ten (10) day VWAP calculated as of the Effective Date of this First Amendment, and subject to compliance with the policies of the CSE (the “Additional True-up Shares”). Prior to the conclusion of the calculation of the actual working capital in accordance with PA #1 and PA #2, Sellers shall complete, execute and deliver to DEP Schedule D to the First Amendment, which shall set forth the amount of Additional True-up Shares each Seller is entitled to (as applicable) and such Additional True-up Shares shall be retitled in accordance with Schedule D to the First Amendment. In the event Schedule D to the First Amendment is not completed, executed and delivered to DEP prior to the conclusion of the calculation of the actual working capital, DEP shall have no obligation to retitle the shares and all Sellers hereby waive any claims against DEP and the Company in connection with such issuance made in accordance with Section 2(b)(v) of the First Amendment. Upon conclusion of the calculation of the actual working capital in accordance with PA #1 and PA #2, the parties agree as follows: (a) If the actual working capital is less than the target working capital of $nil, the Purchase Price (as defined in PA #2) shall be reduced by an amount equal to the difference between the target working capital and the actual working capital and all of the Additional True-up Shares shall be forfeited and retuned to Company for cancellation; (b) If the actual working capital is greater than the target working capital of $nil and the Additional True-up Shares are sufficient to cover the difference between the actual working capital and the target working capital (the “DEP Deficit”), the parties agree that all or a portion of the Additional True-up Shares (valued at the ten (10) day VWAP calculated as of the Effective Date of the First Amendment and subject to compliance with the policies of the CSE) shall be issued to Sellers to satisfy the DEP Deficit owed by DEP to the Sellers in accordance with Section 2.02(b) of PA #2; (c) If the actual working capital is greater than the target working capital and the Additional True-up Shares are insufficient to cover the DEP Deficit, all of the Additional True-up Shares shall be issued to Sellers and the parties agree that any additional amounts owed to the Sellers shall be paid by DEP to the Sellers via additional shares of common stock of the Company. In addition to the terms of the First Amendment, the parties have agreed that the release of any Additional True-up Shares hereunder shall be subject to the Sellers providing written direction to DEP for the release of the Additional True-up Shares payable under the First Amendment.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Apr. 30, 2022
Significant Accounting Policies
Basis of presentation	These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. In the opinion of management, the unaudited consolidated interim financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s fiscal year 2021 Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on 19 November 2021.
Amounts receivable	Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 30 April 2022 and 31 July 2021, the Company has no allowance for doubtful accounts.
Revenue recognition	The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered cash on delivery. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 17 for revenue disaggregation table.
Inventory	Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As of 30 April 2022 and 31 July 2021, the Company has no allowance for inventory obsolescence.
Loans receivable	The Company carries its loans receivable at cost and are reviewed for indicators of impairment at least annually.
Property and equipment	Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease
Intangible assets	Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years, licenses acquired by Canopy have a finite life of 10 years and are amortized over these estimated useful lives on a straight-line basis.
Goodwill	Goodwill represents the excess of the aggregate purchase price paid over the fair value of the net assets acquired in our business combinations. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Events or changes in circumstances that could trigger an impairment review include a significant adverse change in business climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes in the manner of our use of the acquired assets or the strategy for our overall business, significant negative industry or economic trends, or significant underperformance relative to expected historical or projected future results of operations. The Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, additional impairment testing is not required. The Company tests for goodwill impairment annually during its fourth quarter on 31 July.
Income taxes	Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not.
Basic and diluted net loss per share	The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Potentially dilutive options of 9,253,000 and warrants of 17,215,284 existed at 30 April 2022. This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by 1 June 2022, or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until 19 July 2025.
Comprehensive loss	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 30 April 2022 and 31 July 2021, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements.
Foreign currency translation	The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.7755 for monetary assets and liabilities and 0.7916 as an average rate for transactions occurred during the period ended 30 April 2022. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss.
Stock based compensation	The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur.
Fair value measurements	The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The convertible loan receivable was valued using Level 3 inputs. Other current financial assets and current financial liabilities have fair values that approximate their carrying values.
Use of estimates and assumptions	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities, if any, at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates.
Lease accounting	Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment.

Nature and Continuance of Ope_2

Nature and Continuance of Operations (Tables)	9 Months Ended
	Apr. 30, 2022
Nature and Continuance of Operations
Schedule of consolidation of entities and its ownership interest	Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100% 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100% 14 November 2017 NMG Long Beach LLC (“NMG LB”) California, USA 100% 18 December 2018 NMG Cathedral City LLC California, USA 100% 4 January 2019 NMG San Diego LLC (“NMG SD”) California, USA 60% 30 January 2019 NMG Ohio LLC (“NMG Ohio”) Ohio, USA 100% 27 April 2017 NMG OH 1, LLC (“NMG OH 1”) Ohio, USA 100% 29 January 2020 NMG OH P1, LLC (“NMG OH P1”) Ohio, USA 100% 29 January 2020 NMG MI 1, Inc. (“NMG MI 1”) Michigan, USA 100% 24 June 2021 NMG MI C1 Inc. Michigan, USA 100% 24 June 2021 NMG MI P1 Inc. Michigan, USA 100% 24 June 2021 Canopy Monterey Bay, LLC (“Canopy”) California, USA 80%* 1 December 2021

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Apr. 30, 2022
Significant Accounting Policies
Schedule of property and equipment estimated useful lives	Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Apr. 30, 2022
Financial Instruments
Schedule of financial assets at fair value	As of 30 April 2022 As of 31 July 2021 Financial assets at fair value Cash $ 3,706,894 $ 7,374,194 Convertible loan receivable 1,893,252 1,648,816 Total financial assets at fair value $ 5,600,146 $ 9,023,010

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Apr. 30, 2022
Inventory
Schedule of inventory	30 April 2022 31 July 2021 Work in progress $ 610,030 $ 503,215 Finished goods 3,594,580 1,547,493 Consumables 115,294 885,448 Total $ 4,319,904 $ 2,936,156

Investment in NMG Ohio LLC (Tab

Investment in NMG Ohio LLC (Tables)	9 Months Ended
	Apr. 30, 2022
Investment in NMG Ohio LLC (Tables)
Schedule of amounts advanced reclassified as assets in NMG Ohio LLC	30 April 2022 31 July 2021 Loan receivable (payable) to NMG Ohio Opening balance $ 891,279 $ (466,495 ) Advances provided to NMG Ohio 64,598 1,120,015 Foreign exchange - 4,671 Transferred to NMG OH 1 and reclassified to respective net assets acquired (955,877 ) 233,088 Loan receivable from NMG Ohio $ - $ 891,279

Investment in and advances to_2

Investment in and advances to GLDH (Tables)	9 Months Ended
	Apr. 30, 2022
Investment in and advances to GLDH (Tables)
Schedule of total investment in GLDH	Note receivable $ 5,200,000 Share issuances 4,092,175 Share payment reduction (793,416 ) Interest income accrued on the Note 1,821,476 Advances for working capital 2,813,515 Lease Assignment Agreement payment 1,533,765 Amount transferred to Property and Equipment (1,431,585 ) Amount transferred to Brand and Licenses (3,585,483 ) Expensed during the year (690,741 ) Foreign exchange (46,973 ) Balance – 31 July 2020 8,912,733 Impairment loss (534,165 ) Acquisition of ShowGrow Long Beach dispensary (Note 11) – 28 August 2020 $ (8,378,568 )

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Apr. 30, 2022
Property and Equipment
Schedule of property and equipment	Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2021 $ 401,571 $ 466,110 $ 570,702 $ 51,108 $ 38,717 $ 10,335 $ 5,055,799 $ 6,594,342 Additions 57,951 - - 11,994 - - 1,437,163 1,507,108 Balance, 30 April 2022 459,522 466,110 570,702 63,102 38,717 10,335 6,492,962 8,101,450 Accumulated Depreciation: Balance, 31 July 2021 49,765 250,544 210,166 21,722 24,328 1,790 1,142,237 1,700,552 Depreciation 45,687 51,094 58,827 6,101 4,137 1,104 542,291 709,241 Balance, 30 April 2022 95,452 301,638 268,993 27,823 28,465 2,894 1,684,528 2,409,793 Net Book Value: At 31 July 2021 351,806 215,566 360,536 29,386 14,389 8,545 3,913,562 4,893,790 At 30 April 2022 $ 364,070 $ 164,472 $ 301,709 $ 35,279 $ 10,252 $ 7,441 $ 4,808,434 $ 5,691,657

Business Acquisitions (Tables)

Business Acquisitions (Tables)	9 Months Ended
	Apr. 30, 2022
Schedule of Pro Forma	The Clubhouse Dispensary NMG LB Revenue $ 6,103,097 $ 4,213,881 Net income 1,378,818 57,837 Nine months ended 30 April 2021 As Reported Pro Forma (unaudited) Revenue $ 18,765,785 $ 19,843,563 Net income (loss) (2,177,189 ) 259,929
The Clubhouse Dispensary [Member]
Schedule of Purchase consideration	Purchase consideration $ 3,814,788 Assets acquired: Cash 257,462 Amounts receivable 510,367 Prepaid expenses 4,965 Inventory 178,898 Property and equipment 763,951 Licenses and customer relationships 2,710,000 Liabilities assumed: Trade payable and accrued liabilities 443,589 ) Net assets acquired 3,982,054 Bargain purchase (167,266 ) TOTAL $ 3,814,788
ShowGrow Long Beach dispensary
Schedule of Purchase consideration	Purchase consideration $ 8,378,568 Assets acquired: Cash 65,340 Prepaid expenses 15,264 Inventory 177,930 Property and equipment 5,402 Loan receivable (Note 7) 239,834 Liabilities assumed: Trade payable and accrued liabilities (732,262 ) Income taxes payable (423,931 ) Loans payable (Note 14) (12,910 ) Net assets acquired (664,613 ) Brand and licenses 6,510,000 Goodwill 2,533,181 TOTAL $ 8,378,568
Canopy Monterey Bay, LLC [Member]
Schedule of Purchase consideration	Purchase consideration Cash $ 2,500,000 Promissory note 2,300,000 Shares of common stock (Note 16) 939,544 Total consideration – preliminary 5,739,544 Assets acquired: Cash – preliminary 378,503 Inventory – preliminary 630,039 Liabilities assumed: Trade payable and accrued liabilities – preliminary (317,594 ) Net assets acquired – preliminary 690,948 Brand and licenses – preliminary 4,270,000 Goodwill – preliminary 778,596 TOTAL $ 5,739,544

Intangible Assets Net (Tables)

Intangible Assets Net (Tables)	9 Months Ended
	Apr. 30, 2022
Intangible Assets Net
Schedule of Intangible assets	As of 30 April 2022 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 517,000 - $ - $ 517,000 Licenses 24,718,508 10.0 (2,231,921 ) 22,486,587 Customer relationships 90,000 5.0 (29,721 ) 60,279 Total intangible assets $ 25,325,508 $ (2,261,642 ) $ 23,063,866 As of 31 July 2021 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 20,718,508 10.0 (1,184,175 ) 19,534,333 Customer relationships 90,000 5.0 (16,265 ) 73,735 Total intangible assets $ 21,055,508 $ (1,200,440 ) $ 19,855,068
Schedule of The expected amortization of the intangible assets	2022 (remaining) $ 403,021 2023 1,598,943 2024 1,603,324 2025 1,598,943 2026 1,582,678 Thereafter 7,834,958 $ 14,621,867

Related Party Balances and Tr_2

Related Party Balances and Transactions (Tables)	9 Months Ended
	Apr. 30, 2022
Related Party Balances and Transactions
Schedule of related party transactions	For the three months ended 30 April 2022 For the three months ended 30 April 2021 For the nine months ended 30 April 2022 For the nine months ended 30 April 2021 A company controlled by the President, Chief Executive Officer and a director Management fees $ 55,429 $ 40,020 $ 228,425 $ 114,985 A company controlled by the Chief Financial Officer and a director Management fees 23,895 25,512 102,473 71,514 A company controlled by a former director and former President of NMG Management fees - 10,000 - 65,000 A company controlled by the Corporate Secretary Management fees 18,754 19,144 56,217 53,933 $ 98,078 $ 84,676 $ 387,115 $ 305,432

Loan Payable (Tables)

Loan Payable (Tables)	9 Months Ended
	Apr. 30, 2022
Loan receivable
Schedule of fair values assumptions, Warrants	Expected life of the options 4.00 years Expected volatility 139 % Expected dividend yield 0 % Risk-free interest rate 0.55 %

Operating leases (Tables)

Operating leases (Tables)	9 Months Ended
	Apr. 30, 2022
Operating Leases
Schedule of supplemental cash flow information related to leases	Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 583,427 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 3,896,652 Weighted-average remaining lease term – operating leases 7.88 years Weighted-average discount rate – operating leases 12 %
Schedule of maturities of lease liabilities	Year Ending 31 July Operating Leases 2022 (remaining) $ 275,399 2023 1,542,189 2024 1,101,214 2025 1,157,278 2026 and thereafter 5,162,344 Total lease payments $ 9,241,424 Less imputed interest (3,270,643 ) Total $ 5,970,781 Less current portion (886,202 ) Long term portion $ 5,084,579

Capital Stock (Tables)

Capital Stock (Tables)	9 Months Ended
	Apr. 30, 2022
Capital Stock
Schedule of stock option activity	Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2021 9,855,000 CAD$0.70 2.30 CAD$ - Granted 648,000 CAD$0.44 3.97 CAD$ - Cancelled (1,250,000 ) CAD$0.70 0.92 CAD$ - Outstanding at 30 April 2022 9,253,000 CAD$0.69 2.30 CAD$ - Vested and fully exercisable at 30 April 2022 8,180,000 CAD$0.70 2.05 CAD$ -
Schedule of number of warrants outstanding and exercisable	Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 4,800,000 USD$0.40 19 July 2025 17,215,284 (1)

Segmented Information and Maj_2

Segmented Information and Major Customers (Tables)	9 Months Ended
	Apr. 30, 2022
Schedule of Segment revenue and operating income	30 April 2022 Revenue Wholesale $ 4,303,780 Retail 19,190,236 Total $ 23,494,016 Net income (loss) before income taxes Wholesale $ 208,574 Retail 1,932,547 All others (5,063,888 ) Total $ (2,922,766 )

Supplemental Disclosures with_2

Supplemental Disclosures with Respect to Cash Flows (Tables)	9 Months Ended
	Apr. 30, 2022
Supplemental Disclosures with Respect to Cash Flows
Schedule of supplemental disclosures with respect to cash flows	Nine Months Ended 30 April 2022 2021 Cash paid during the period for interest $ 657,222 $ - Cash paid during the period for income taxes $ 1,075 $ 49,146

Nature and Continuance of Ope_3

Nature and Continuance of Operations (Details)	9 Months Ended
	Apr. 30, 2022	Oct. 31, 2021	Apr. 30, 2020	Jul. 03, 2019
NMG San Diego LLC [Member]
Date of acquisition or formation	30 January 2019
Ownership		60%	60%	60%
Jurisdiction	California, USA
NMG Ohio LLC
Date of acquisition or formation	27 April 2017
Ownership		100%
Jurisdiction	Ohio, USA
DEP Nevada Inc [Member]
Date of acquisition or formation	10 August 2017
Ownership		100%
Jurisdiction	Nevada, USA
Nevada Medical Group LLC [Member]
Date of acquisition or formation	14 November 2017
Ownership		100%
Jurisdiction	Nevada, USA
NMG Long Beach LLC [Member]
Date of acquisition or formation	18 December 2018
Ownership		100%
Jurisdiction	California, USA
NMG Cathedral City LLC [Member]
Date of acquisition or formation	4 January 2019
Ownership		100%
Jurisdiction	California, USA
NMG OH 1, LLC
Date of acquisition or formation	29 January 2020
Ownership		100%
Jurisdiction	Ohio, USA
NMG OH P1, LLC [Member]
Date of acquisition or formation	29 January 2020
Ownership		100%
Jurisdiction	Ohio, USA
NMG MI 1, Inc
Date of acquisition or formation	24 June 2021
Ownership		100%
Jurisdiction	Michigan, USA
NMG MI C1 Inc. [Member]
Date of acquisition or formation	24 June 2021
Ownership		100%
Jurisdiction	Michigan, USA
NMG MI P1 Inc. [Member]
Date of acquisition or formation	24 June 2021
Ownership		100%
Jurisdiction	Michigan, USA
Monterey Bay, LLC [Member]
Date of acquisition or formation	1 December 2021
Ownership		80%
Jurisdiction	California, USA

Nature and Continuance of Ope_4

Nature and Continuance of Operations (Details Narrative)	9 Months Ended
	Apr. 30, 2022	May 31, 2004
State of incorporation	Delaware
Represents information related to Vocalscape, Inc.
Ownership		100%

Significant Accounting Polici_4

Significant Accounting Policies (Details)	9 Months Ended
	Apr. 30, 2022
Leasehold Improvements [Member]
Estimated Useful Life	shorter of useful life or the term of the lease
Office Equipment [Member]
Estimated useful lives	7 years
Cultivation equipment [Member]
Estimated useful lives	7 years
Production Equipment [Member]
Estimated useful lives	7 years
Kitchen equipment [Member]
Estimated useful lives	7 years
Vehicles [Member]
Estimated useful lives	7 years
Vault equipment [Member]
Estimated useful lives	7 years

Significant Accounting Polici_5

Significant Accounting Policies (Details Narrative)	9 Months Ended
	Apr. 30, 2022 $ / shares shares
Dilutive options and warrants existed | shares	17,215,284
Exercise price | $ / shares	$ 0.45
Exchange rates | $ / shares	0.7755
Assets and liabilities | $ / shares	$ 0.7916
Brands and licenses acquired by NMG LB and NMG OH 1
Dilutive options and warrants existed | shares	9,253,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Brands and licenses acquired by NMG SD
Dilutive options and warrants existed | shares	3,200,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Brands and licenses acquired by Canopy
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years

Financial Instruments (Details)

Financial Instruments (Details) - USD ($)	Apr. 30, 2022	Jul. 31, 2021
Financial Instruments
Cash	$ 3,706,894	$ 7,374,194
Convertible loan receivable	1,893,252	1,648,816
Total financial assets at fair value	$ 5,600,146	$ 9,023,010

Financial Instruments (Details

Financial Instruments (Details Narrative)	Apr. 30, 2022 USD ($)
Financial Instruments
Working capital deficit	$ 2,422,715

Inventory (Details)

Inventory (Details) - USD ($)	Apr. 30, 2022	Jul. 31, 2021
Inventory
Work in progress	$ 610,030	$ 503,215
Finished goods	3,594,580	1,547,493
Consumables	115,294	885,448
Total	$ 4,319,904	$ 2,936,156

Convertible loan receivable (De

Convertible loan receivable (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021	Jul. 31, 2021
Loan receivable	$ 1,893,252		$ 1,893,252		$ 1,648,816
Interests receivable	204,000		204,000		$ 150,000
Accrued interest income	18,000	$ 18,000	54,000	$ 54,000
Loan receivable balance	$ 1,893,252		$ 1,893,252
CCG | Convertible Loan Agreement
Outstanding units percentage	40%		40%
Proceeds from fund construction	$ 1,250,000		$ 1,250,000
NMG [Member]
Management fee (per month)			$ 6,000
Percentage of monthly management fee			66.67%
Loan bears interest per month	$ 6,000		$ 6,000
Management agreement expiring date			Mar. 15, 2024

Loan receivable (Details Narrat

Loan receivable (Details Narrative) - USD ($)	Apr. 30, 2022	Jul. 31, 2021
Convertible loan receivable
Loan receivable	$ 239,834	$ 239,834

Investment in NMG Ohio LLC (Det

Investment in NMG Ohio LLC (Details) - USD ($)	9 Months Ended	12 Months Ended
	Apr. 30, 2022	Jul. 31, 2021
Loan receivable (payable) to NMG Ohio
Opening balance Loan	$ 891,279	$ (466,495)
Advances provided to NMG Ohio	64,598	1,120,015
Foreign exchange	0	4,671
Transferred to NMG OH 1 and reclassified to respective net assets acquired	(955,877)	233,088
Loan receivable to NMG Ohio	$ 0	$ 891,279

Investment in NMG Ohio LLC (D_2

Investment in NMG Ohio LLC (Details Narrative) - NMG Ohio LLC - USD ($)	1 Months Ended
	Jan. 31, 2019	Apr. 30, 2022
Percentage of voting interest acquired	100%
Purchase of remaining ownership interest percentage	70%	70%
Consideration in cash to be paid for the acquisition of remaining interest	$ 1,575,000
Share issue costs (in shares)	3,173,864
Ownership percentage		30%

Investment in and advances to_3

Investment in and advances to GLDH (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021	Jul. 31, 2021
Interest income accrued on the Note	$ 18,000	$ 21,252	$ 54,000	$ 146,619
Lease Assignment Agreement payment			583,427
Foreign exchange			0		$ 4,671
GLDH
Note receivable			5,200,000
Share issuances			4,092,175
Share payment reduction			(793,416)
Interest income accrued on the Note			1,821,476
Advances for working capital			2,813,515
Lease Assignment Agreement payment			1,533,765
Amount transferred to Property and Equipment			(1,431,585)
Amount transferred to Brand and Licenses			(3,585,483)
Expensed during the year			(690,741)
Foreign exchange			(46,973)
Total investment			8,912,733
Impairment loss			(534,165)
Acquisition of ShowGrow Long Beach dispensary (Note 11)			$ (8,378,568)

Investment in and advances to_4

Investment in and advances to GLDH (Details Narrative)		1 Months Ended	12 Months Ended
	Jul. 03, 2019 USD ($) shares	Apr. 30, 2020 USD ($)	Jul. 31, 2020 USD ($)	Jul. 31, 2019 USD ($)	Oct. 31, 2021	Jul. 03, 2019 $ / shares
David Barakett
Payment of consulting and advisory services	$ 200,000			$ 50,000
Payment of consulting and advisory services in subsequent to year end			$ 150,000
NMG San Diego LLC [Member]
Ownership percentage	60%	60%			60%
Percentage of consolidated assets liabilities of subsidiary	100%
Percentage of disclosed non-controlling interest of subsidiary.		40%
GLDH
Loan, face amount	$ 200,000
Operating loans		$ 800,000
Interest rate per annum	12%
GLDH | Eligibility condition one
Amount to be paid in common shares	$ 1,500,000
Share price per share | $ / shares						$ 0.7439
Maximum number of common shares | shares	2,681,006
GLDH | Eligibility condition one | David Barakett
Amount to be paid in common shares	$ 500,000
Maximum number of common shares | shares	624,380
GLDH | Eligibility condition three | David Barakett
Amount to be paid in common shares	$ 750,000
Share price per share | $ / shares						0.7439
Maximum number of common shares | shares	1,340,502
GLDH | Eligibility condition two | David Barakett
Amount to be paid in common shares	$ 750,000
Share price per share | $ / shares						$ 0.7439
Maximum number of common shares | shares	1,340,502
GLDH | Purchase Agreement
Investment purchase price	$ 6,700,000
Note to be applied towards the Purchase Price	$ 5,200,000
GLDH | Information about Subsidiary.
Ownership percentage	60%
SGSD | Eligibility condition one
Amount to be paid in common shares	$ 700,000
Maximum number of common shares | shares	1,031,725
SGSD | Eligibility condition two
Amount to be paid in common shares	$ 783,765
Green Light District Management, LLC and GLDH (collectively referred to as "Licensor").
Licensor grants	2 years

Property and Equipment (Details

Property and Equipment (Details)	9 Months Ended
	Apr. 30, 2022 USD ($)
Accumulated Depreciation, beginning balance	$ 1,700,552
Accumulated Depreciation, ending balance	2,409,793
Depreciation	709,241
Net Book Value, beginning balance	4,893,790
Net Book Value, ending balance	5,691,657
Cost, ending Balance	8,101,450
Cost, beginning Balance	6,594,342
Additions	1,507,108
Leasehold Improvements [Member]
Accumulated Depreciation, beginning balance	1,142,237
Accumulated Depreciation, ending balance	1,684,528
Depreciation	542,291
Net Book Value, beginning balance	3,913,562
Net Book Value, ending balance	4,808,434
Cost, ending Balance	6,492,962
Cost, beginning Balance	5,055,799
Additions	1,437,163
Office Equipment [Member]
Accumulated Depreciation, beginning balance	49,765
Accumulated Depreciation, ending balance	95,452
Depreciation	45,687
Net Book Value, beginning balance	351,806
Net Book Value, ending balance	364,070
Cost, ending Balance	459,522
Cost, beginning Balance	401,571
Additions	57,951
Cultivation equipment [Member]
Accumulated Depreciation, beginning balance	250,544
Accumulated Depreciation, ending balance	301,638
Depreciation	51,094
Net Book Value, beginning balance	215,566
Net Book Value, ending balance	164,472
Cost, ending Balance	466,110
Cost, beginning Balance	466,110
Additions	0
Production Equipment [Member]
Accumulated Depreciation, beginning balance	210,166
Accumulated Depreciation, ending balance	268,993
Depreciation	58,827
Net Book Value, beginning balance	360,536
Net Book Value, ending balance	301,709
Cost, ending Balance	570,702
Cost, beginning Balance	570,702
Additions	0
Kitchen equipment [Member]
Accumulated Depreciation, beginning balance	21,722
Accumulated Depreciation, ending balance	27,823
Depreciation	6,101
Net Book Value, beginning balance	29,386
Net Book Value, ending balance	35,279
Cost, ending Balance	63,102
Cost, beginning Balance	51,108
Additions	11,994
Vehicles [Member]
Accumulated Depreciation, beginning balance	24,328
Accumulated Depreciation, ending balance	28,465
Depreciation	4,137
Net Book Value, beginning balance	14,389
Net Book Value, ending balance	10,252
Cost, ending Balance	38,717
Cost, beginning Balance	38,717
Additions	0
Vault equipment [Member]
Accumulated Depreciation, beginning balance	1,790
Accumulated Depreciation, ending balance	2,894
Depreciation	1,104
Net Book Value, beginning balance	8,545
Net Book Value, ending balance	7,441
Cost, ending Balance	10,335
Cost, beginning Balance	10,335
Additions	$ 0

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Property and Equipment
General and administrative expenses	$ 556,924	$ 322,109
Depreciation	$ 152,317	$ 56,934

Business Acquisitions (Details)

Business Acquisitions (Details) - USD ($)		1 Months Ended
	Sep. 04, 2020	Nov. 30, 2021	Aug. 28, 2020	Apr. 30, 2022	Jul. 31, 2021
Liabilities assumed:
Goodwill				$ 5,947,498	$ 5,168,902
The Clubhouse Dispensary [Member]
Purchase consideration (Note 8)	$ 3,814,788
Assets acquired:
Cash	257,462
Amounts receivable	510,367
Prepaid expenses	4,965
Inventory	178,898
Property and equipment	763,951
Licenses and customer relationships	2,710,000
Liabilities assumed:
Trade payable and accrued liabilities	(443,589)
Net assets acquired	3,982,054
Bargain purchase	(167,266)
TOTAL	$ 3,814,788
ShowGrow Long Beach dispensary
Purchase consideration (Note 8)			$ 8,378,568
Assets acquired:
Cash			65,340
Prepaid expenses			15,264
Inventory			177,930
Property and equipment			5,402
Liabilities assumed:
Trade payable and accrued liabilities			(732,262)
Net assets acquired			8,378,568
TOTAL			8,378,568
Assets acquired:
Loan receivable (Note 7)			239,834
Liabilities assumed:
Income taxes payable			(423,931)
Loans payable (Note 14)			(12,910)
Net liabilities acquired			(664,613)
Brand and licenses			6,510,000
Goodwill			$ 2,533,181
Canopy Monterey Bay, LLC [Member] | Second Purchase Agreements [Member]
Purchase consideration (Note 8)		$ 5,739,544
Assets acquired:
Cash		378,503
Inventory		630,039
Liabilities assumed:
Trade payable and accrued liabilities		(317,594)
Net assets acquired		5,739,544
Liabilities assumed:
Brand and licenses		4,270,000
Goodwill		778,596
Cash		2,500,000
Promissory note		2,300,000
Shares of common stock (Note 16)		939,544
Net assets acquired - preliminary		$ 690,948

Business Acquisitions (Details

Business Acquisitions (Details 1)	9 Months Ended
	Apr. 30, 2022 USD ($)
Revenue	$ 18,765,785
Net income	(2,177,189)
The Clubhouse Dispensary [Member]
Revenue	6,103,097
Net income	1,378,818
NMG Long Beach LLC [Member]
Revenue	4,213,881
Net income	$ 57,837

Business Acquisitions (Detail_2

Business Acquisitions (Details 2)	9 Months Ended
	Apr. 30, 2022 USD ($)
Revenue	$ 18,765,785
Net income	(2,177,189)
Pro Forma [Member]
Revenue	19,843,563
Net income	$ 259,929

Business Acquisitions (Detail_3

Business Acquisitions (Details Narrative) - USD ($)		1 Months Ended		9 Months Ended
	Sep. 04, 2020	Dec. 01, 2021	Nov. 30, 2021	Apr. 30, 2022
First part of acquisition of the remaining interest in NMG Ohio	70%
Number of share issued				2,728,156
Canopy Monterey Bay, LLC [Member]
Ownership percentage			100%
Canopy Monterey Bay, LLC [Member] | Second Purchase Agreement
Ownership percentage			20%
Membership interests			80%
Cash consideration deposited in escrow account		$ 2,500,000
Promissory notes deposited in escrow account		$ 2,300,000
Common stock issued			$ 1,000,000
Per share common stock issued			$ 0.3665
Number of share issued			2,728,156
Additonal number share issued			100,000

Intangible Assets Net (Details)

Intangible Assets Net (Details) - USD ($)	9 Months Ended	12 Months Ended
	Apr. 30, 2022	Jul. 31, 2021
Gross carrying amount	$ 25,325,508	$ 21,055,508
Accumulated amortization	(2,261,642)	1,200,440
Net carrying amount	23,063,866	19,855,068
Brand
Gross carrying amount	517,000	247,000
Accumulated amortization	0	0
Net carrying amount	517,000	247,000
Licenses
Gross carrying amount	24,718,508	20,718,508
Accumulated amortization	(2,231,921)	(1,184,175)
Net carrying amount	$ 22,486,587	$ 19,534,333
Weighted average life (years)	10 years	10 years
Customer relationships
Gross carrying amount	$ 90,000	$ 90,000
Accumulated amortization	(29,721)	(16,265)
Net carrying amount	$ 60,279	$ 73,735
Weighted average life (years)	5 years	5 years

Intangible Assets Net (Details

Intangible Assets Net (Details 1)	Apr. 30, 2022 USD ($)
Intangible Assets Net (Details)
2022	$ 403,021
2023	1,598,943
2024	1,603,324
2025	1,598,943
2026	1,582,678
Thereafter	7,834,958
Total	$ 14,621,867

Intangible Assets Net (Detail_2

Intangible Assets Net (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2021	Apr. 30, 2022
Intangible Assets Net (Details)
Amortization expenses	$ 389,879	$ 292,398	$ 775,692	$ 1,061,201
License fees				$ 7,925,000

Related Party Balances and Tr_3

Related Party Balances and Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
Management fees	$ 98,078	$ 84,676	$ 387,115	$ 305,432
Corporate Secretary [Member]
Management fees	18,754	19,144	56,217	53,933
President And Chief Executive Officer [Member]
Management fees	55,429	40,020	228,425	114,985
Chief Financial Officer And Director [Member]
Management fees	23,895	25,512	102,473	71,514
Former Director And Former President [Member]
Management fees	$ 0	$ 10,000	$ 0	$ 65,000

Related Party Balances and Tr_4

Related Party Balances and Transactions (Details Narrative) - USD ($)		1 Months Ended
	Nov. 12, 2021	Nov. 30, 2021	Apr. 30, 2022	Jul. 31, 2021
Description of earnings	$5,000 in cash for each 1% revenue growth over the prior quarter, and/or (ii) $10,000 in cash for each 1% Adjusted EBITDA growth over the prior quarter, all subject to a $50,000 maximum amount per executive
Aggregate of stock options		448,000
Exercise price		$ 0.44
Expiration period		5 years
Description of vesting		25% of the Options vest six (6) months from the date of grant, 25% of the Options vest twelve (12) months from the date of grant, 25% of the Options vest eighteen (18) months from the date of grant and 25% of the Options vest twenty-four (24) months from the date of grant
Due to Related Parties, Current			$ 46,720	$ 52,074
Corporate Secretary [Member]
Due to Related Parties, Current			6,299	6,319
Chief Financial Officer One [Member]
Due to Related Parties, Current			10,744	18,914
Incentive-based cash bonus program	$ 200,000
Cash bonus	40,000
Quarterly bonus	10,000
Chief Executive Officer [Member]
Due to Related Parties, Current			$ 5,246	$ 26,841
Incentive-based cash bonus program	$ 200,000

Loan Payable (Detail)

Loan Payable (Detail) - Warrants [Member]	9 Months Ended
	Apr. 30, 2022
Expected life of the options	4 years
Expected volatility	139%
Expected dividend yield	0%
Risk-free interest rate	0.55%

Loan Payable (Details Narrative

Loan Payable (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended
	Nov. 30, 2021	Jul. 19, 2021	Apr. 30, 2022	Apr. 30, 2021
Loan mature		19 July 2025
Bearing interest rate		13%
Warrants issued for services , shares			4,800,000
Warrants issued for services , amount			$ 1,037,146
Legal fees and other fees			175,758
Warrant exercise price per share		$ 0.45
Amortization of debt discount			356,732	$ 0
Interest expense			$ 657,222
Initial interest	80%
Promissory note	$ 2,300,000
Purchase of the issued and outstanding membership interests			80%
Loan		$ 4,444,444
Advanced loan		$ 4,000,000
Origination discount		10%
Unamortized debt discount		$ 1,511,063
Exercise price per share			$ 0.45
Agent [Member]
Loan		6,666,667
Advanced loan		$ 6,000,000
Origination discount		10%
Warrants [Member]
Aggregate purchase common stock shares		8,000,000
Acquire common stock shares		4,800,000
Exercise price per share		$ 0.40
Escrowed shares		3,200,000
Term Loan mature		Jul. 19, 2025

Operating Leases (Details)

Operating Leases (Details)	9 Months Ended
	Apr. 30, 2022 USD ($)
Operating Leases
Operating cash flows from operating leases	$ 583,427
Operating leases	$ 3,896,652
Weighted-average discount rate - operating leases	12%
Weighted-average remaining lease term - operating leases	7 years 10 months 17 days

Operating Leases (Details 1)

Operating Leases (Details 1)	Apr. 30, 2022 USD ($)
Operating Leases
2022 (remaining)	$ 275,399
2023	1,542,189
2024	1,101,214
2025	1,157,278
2026 and thereafter	5,162,344
Total lease payments	9,241,424
Less imputed interest	(3,270,643)
Total	5,970,781
Less current portion	886,202
Long term portion	$ 5,084,579

Operating Leases (Details Narra

Operating Leases (Details Narrative) - USD ($)

1 Months Ended

9 Months Ended

Feb. 10, 2020

Apr. 09, 2019

Aug. 02, 2018

Nov. 10, 2017

Apr. 23, 2021

Aug. 28, 2020

Apr. 24, 2020

Apr. 30, 2022

Oct. 31, 2021

Sep. 21, 2021

Sep. 14, 2021

Jul. 31, 2021

Jan. 01, 2020

Lease expense

$ 709,561

Deposits

107,290

Accrued milestone

150,000

$ 200,000

Settlement of accrued milestone by shares

75,000

$ 200,000

Operating lease liability milestone

200,000

Remaning accured milestone

75,000

Amortization of right-of-use assets included in General and Administrative Expenses

600,178

Amortization of right-of-use assets included in Cost of Sales

109,383

Operating lease, right-of-use asset and increase in lease liabilities

470,546

Lease expense (Monthly)

$ 22,500

Periodic rent payable amount

$ 9,000

1 October 2021 [Member]

Lease expense (Monthly)

$ 5,000

$ 5,000

Percent of rent increase by

2%

NMG [Member]

Periodic rent payable amount

7,500

$ 6,478

$ 4,200

$ 7,682

$ 15,450

$ 4,000

Issued common share upon achieving certain milestones

600,000

$ 150,000

Current rent

$ 16,883

Common share issued on receiving local and state commercial marihuana cultivation licenses

200,000

Common share issued on receiving local operating permit to begin commercial marihuana cultivation operation

200,000

Common share issued on receiving local and state commercial marihuana retail licenses

100,000

Common share issued on Common share issued on receiving local operating permit to begin commercial marihuana retail operation

$ 100,000

Description for lease option to extend

increases 2% annually

The Company has one option to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term

5% starting on 1 July 2021 and 1 July 2024

The Company has four options to extend the lease and each option is for five years

The Company has three options to extend the lease and each option is for five years

by 3% every year until 10 January 2022

The Company has three options to extend the lease and each option is for five years

Description for change in rent

5% starting on 1 July 2021 and 1 July 2024

2% increase on each anniversary date of the lease

3% every year until 1 December 2022

Description for provision of bonus

The lease contains a sale bonus provision of $1,000,000 or 10% of the purchase price of the entire business, whichever is greater, in the event of sale or assignment of the lease

Provision of bonus

$ 1,000,000

Percent of common stock issued after MI 1passing final inspection

25%

Discount rate for present value of future lease payments

10%

12%

Percent of common stock issued after receipt of local commercial license

25%

Percent of common stock issued after passing final inspection

25%

Percent of common stock issued after receipt of local commercial Adult use of license

25%

NMG [Member] | From January 1, 2019 [Member]

Periodic rent payable amount

$ 12,500

NMG [Member] | From December 1, 2019 [Member]

Periodic rent payable amount

$ 13,663

NMG MI P1[Member]

Accrued milestone

200,000

Settlement of accrued milestone by shares

200,000

Operating lease liability milestone

$ 200,000

Issued common share upon achieving certain milestones

$ 400,000

Common share issued on receiving local and state commercial marihuana processing licenses

200,000

Common share issued on receiving operating permit to begin commercial marihuana processing operation

$ 200,000

Accounting Standards Update 2016-02 [Member]

Discount rate for present value of future lease payments

12%

Capital Stock (Details)

Capital Stock (Details) - Share-based Payment Arrangement, Option [Member] - USD ($)	1 Months Ended	9 Months Ended
	Jul. 31, 2021	Apr. 30, 2022
Outstanding number of share	9,855,000	9,253,000
Granted, number of share		648,000
Cancelled, number of share		1,250,000
Vested and fully excersisable		8,180,000
Weighted average exercise price, outstanding	$ 0.70	$ 0.69
Weighted average exercise price, granted		0.44
Weighted average exercise price, cancelled		0.70
Weighted average exercise price, vested and fully exersisable		$ 0.70
Weighted average contractual term remaining (in years)	2 years 3 months 18 days	2 years 3 months 18 days
Weighted average contractual term remaining (in years) granted		3 years 11 months 19 days
Weighted average contractual term remaining (in years) cancelled		11 months 1 day
Weighted average contractual term remaining (in years), Vested and fully exercisable		2 years 18 days
Aggregate intrinsic value outstanding	$ 0	$ 0
Aggregate intrinsic value granted		$ 0
Aggregate intrinsic value cancelled		$ 0
Aggregate intrinsic value, Vested and fully exercisable		$ 0

Capital Stock (Details 1)

Capital Stock (Details 1) - $ / shares	3 Months Ended
	Apr. 30, 2022	Jul. 31, 2021
Range One [Member]
Number of warrants outstanding and exercisable	11,780,134	11,780,134
Warrants price per share	$ 1.50	$ 1.50
Expire date	17 May 2023
Range Two [Member]
Number of warrants outstanding and exercisable	635,150	635,150
Warrants price per share	$ 1.25	$ 1.25
Expire date	16 May 2023
Range Three [Member]
Number of warrants outstanding and exercisable	4,800,000	4,800,000
Warrants price per share	$ 0.40	$ 0.40
Expire date	19 July 2025
Range Four [Member]
Number of warrants outstanding and exercisable	17,215,284	17,215,284
Warrants price per share		$ 1.21

Capital Stock (Details Narrativ

Capital Stock (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

Nov. 30, 2021

Oct. 21, 2020

Apr. 30, 2022

Jan. 31, 2022

Apr. 30, 2021

Jan. 31, 2020

Jan. 31, 2021

Apr. 30, 2022

Apr. 30, 2021

Sep. 21, 2021

Jul. 31, 2021

Jul. 19, 2021

Common shares in escrow

2,681,006

Description of capital stock

the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025

Stock option granted

11,334,946

Stock option outstanding

9,253,000

Capital stock, par value

$ 0.0001

$ 0.0001

$ 0.0001

$ 0.0001

Share based compensation expense

$ 91,383

$ 149,769

$ 244,276

$ 149,769

$ 488,822

$ 386,327

$ 733,098

Capital stock, shares authorized

900,000,000

900,000,000

900,000,000

900,000,000

Number of share issued

2,728,156

Acquiring remaining interest, percentage

10%

Exercise price

$ 0.45

NMG [Member]

Acquiring remaining interest, percentage

70%

Amount related to issued common shares

$ 297,042

Number of common shares issued

793,466

Two Officers And Directors

Stock option granted

448,000

Expiry date

30 November 2024

Exercise price

$ 0.44

Description of vest period

stock options vest equally every 6 months for a period of 24 months

Consultant [Member]

Stock option granted

200,000

Expiry date

30 November 2026

Exercise price

$ 0.44

Lease agreement for a premises in Muskegon, Michigan [Member]

Common stock shares issued under agreement

238,929

Lease agreement for a premises in Manistee, Michigan [Member]

Common stock shares issued under agreement

1,304,601

Segmented Information and Maj_3

Segmented Information and Major Customers (Details) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
Revenue	$ 7,876,674	$ 7,156,016	$ 23,494,016	$ 18,765,785
Net loss	$ (1,640,786)	$ 724,735	(2,922,766)	$ 463,338
Retail [Member]
Revenue			19,190,236
Operating income (loss)			(1,932,547)
Wholesale [Member]
Revenue			4,303,780
Operating income (loss)			(208,574)
All others [Member]
Operating income (loss)			$ (5,063,888)

Supplemental Disclosures with_3

Supplemental Disclosures with Respect to Cash Flows (Details) - USD ($)	6 Months Ended	9 Months Ended
	Jan. 31, 2021	Apr. 30, 2022
Supplemental Disclosures with Respect to Cash Flows (Details)
Cash paid during the year for interest	$ 0	$ 657,222
Cash paid during the period for income taxes	$ 49,146	$ 1,075

Supplemental Disclosures with_4

Supplemental Disclosures with Respect to Cash Flows (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Sep. 21, 2021	Apr. 30, 2022	Jul. 31, 2021
Common shares	2,728,156	113,349,464	109,077,778
Number of share issued		2,728,156
Lease agreement for a premises in Muskegon, Michigan [Member]
Common stock shares issued under agreement	238,929
Lease agreement for a premises in Manistee, Michigan [Member]
Common stock shares issued under agreement	1,304,601
Lease agreement for Elyria, Ohio and Muskegon, Michigan, [Member]
Discount rate used to calculate present value	12%
Change in lease liabilities	$ 3,896,652

Commitments (Details Narrative)

Commitments (Details Narrative)		1 Months Ended		9 Months Ended
	Feb. 10, 2020 USD ($)	Sep. 30, 2021 shares	Oct. 30, 2018 USD ($)	Apr. 30, 2022 USD ($) shares	Apr. 30, 2022 CAD ($) $ / shares shares	Sep. 21, 2021 shares	Jul. 31, 2021 shares	Jul. 19, 2021 $ / shares
Term of contract				5 years	5 years
Increased in periodic payments of consulting fees | $			$ 16,500
Ownership percentage for increased in monthly services fee				10%	10%
Frequency of periodic payment			monthly
Periodic consulting fees payable | $			$ 10,000	$ 12,000
Common shares in escrow | shares					113,349,464	2,728,156	109,077,778
Lease expense (Monthly) | $	$ 22,500
Option price | $ / shares								$ 0.45
Australis Capital Inc. [Member]
Restricted shares issued by related party in a private transaction | shares		9,900,000
Ownership percentage		10%
Skanderbeg Capital Advisors Inc
Lease expense (Monthly) | $					$ 7,500
One-time payment of options | shares				200,000	200,000
Option price | $ / shares					$ 0.44
ShowGrow Long Beach dispensary
Common shares in escrow | shares					2,681,006

Other Agreement (Details Narrat

Other Agreement (Details Narrative)	Apr. 30, 2022
Supplemental Disclosures with Respect to Cash Flows (Details)
Lotery with a pool of agrrement	85%

Subsequent Event (Details Narra

Subsequent Event (Details Narrative) - USD ($)		1 Months Ended
	Jun. 01, 2022	Jun. 17, 2022	Jun. 15, 2022	Apr. 30, 2022	Sep. 21, 2021	Jul. 31, 2021
Term loan				$ 7,455,603		$ 4,798,871
Common shares in escrow				113,349,464	2,728,156	109,077,778
Subsequent Event [Member]
Term loan			$ 4,440,000
Advanced			$ 4,000,000
Interest rate			2%
Exit fee			1.50%
Common shares in escrow			1,000,000
Exercise price			$ 0.16
Subsequent Event, Description		Additionally, on the date that is eighteen (18) months (548 days) following the Effective Date of this First Amendment (the “Additional Share Issuance Date”) the Company will issue US$100,000 worth of shares to the Sellers based on the ten (10) day VWAP and subject to compliance with the policies of the CSE, calculated as of the Additional Share Issuance Date. Furthermore, DEP shall cause the Company to issue to Mr. Stiebel Three Hundred Thousand Dollars (US$300,000.00) worth of shares of common stock of the Company within three (3) days following the Effective Date of this First Amendment, which shall be priced at the ten (10) day VWAP calculated as of the Effective Date of this First Amendment
Subsequent Event [Member] | Lease Agreement One [Member]
Lease	$ 4,482
Lease year	3 years
Subsequent Event [Member] | Minimum [Member]
Common shares in escrow		1,250,000
Interest rate			15%
Purchase price reduced		$ 2,500,000
Subsequent Event [Member] | Maximum [Member]
Interest rate			13%
Purchase price reduced		$ 1,250,000